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1. Introduction 
1.1. Craniomaxillofacial osteosynthesis implants 
1.1.1. Osteosynthesis implants for craniomaxillofacial applications 
Bone fracture is a significant challenge for health, affecting hundreds of millions 
of people worldwide. At least tens of millions of fractures occur worldwide 
annually, at which approximately 20% of cases were treated with rigid internal 
fixation with osteosynthesis implants, such as plates, screws and meshes [1, 2]. 
The demand for osteosynthesis implants is closely linked to the increasing cases 
of bone fractures caused by accidents or sports injuries [3, 4]. 
For bone fracture treatment, the principle of osteosynthesis is the anatomical 
repair and its functional restoration. Osteosynthesis implants are widely used for 
bone fixation, to fix and support the bone fragments and induce tissue 
remodelling and healing [1, 2]. Craniomaxillofacial (CMF) osteosynthesis 
implants, mainly including mini-plates, mini-screws and meshes, are frequently 
used in craniomaxillofacial surgery, such as internal fixation of fractures, 
orthognathic surgery and osteotomies [5, 6]. To achieve the function, the basic 
requirements of osteosynthesis materials have to meet are excellent 
biocompatibility and biomechanical properties, resistance to pressure load and 
deformation. 
1.1.2. Main issues of bioinert implants 
To date, bioinert osteosynthesis implants are commonly manufactured from 
titanium (Ti) and its alloys mainly due to excellent biocompatibility and superior 
strength [7, 8]. Nonetheless, bioinert materials are facing several disadvantages 
and issues for osteosynthesis applications. 
Firstly, the strength mismatch between bone and metallic implant might cause 
stress shielding, leading to re-fracture especially in osteoporotic patients [9]. As 
listed in Table 1.1, the inhomogeneous stress transfer can be attributed to the 
higher Young’s modulus of metallic materials (i.e. Ti, 316L SS and Co-Cr-Mo alloy) 
compared with that of the cortical bone, which also affects new bone growth and 
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remodeling [10, 11]. Furthermore, several adverse side effects and postoperative 
complications for bioinert materials have been documented after long-term 
observation, such as the release of toxic metallic ions and particles, foreign body 
host response, interference with diagnostic imaging, metal hypersensitivity and 
thermal conductivity [12-14]. In addition, the clinical use of bioinert osteosynthesis 
implants is restricted for pediatric cases because they can lead to the possibility 
of growth disturbance [5]. Finally, the additional surgery to remove these implants 
may lead to postoperative complications and potential risks, including infection, 
re-fracture, neurovascular injury, etc. [15, 16]. Therefore, to overcome the 
disadvantages above, the development and investigation of novel absorbable 
materials have gained increasing attention. 
Table 1.1. Mechanical properties of bone tissue and osteosynthesis materials. 
Tissue/Materials 
YS 
(MPa) 
UTS 
(MPa) 
Elongation 
(%) 
Modulus 
(GPa) 
Ref. 
Cortical bone - 164-240 1.0-2.1 7-30 [2, 8] 
Bioinert matatials 
As-rolled pure Ti  483 550 15 114 [17] 
As cast Ti-6Al-4V  834 937 19 114 [18] 
316L SS 190 490 40 193 [19] 
Co-Cr-Mo alloy 
500-
1500 
900-
1540 
- 240 [8] 
Bioresorbable polymer 
PGA - 
60.0-
99.7 
1.5-20 - [20] 
PLA - 48-53 30-240 1.9-2.4 [8, 21] 
Absorbable metals 
As-cast pure Mg 20 86 13 41 [8, 19] 
WE43 195.2 280.6 10.3 - [22] 
Annealed pure Fe 140 205 25.5 - [23] 
As-cast pure Zn 10 18 0.3  [24] 
As-rolled pure Zn 28 45 5.6 - [24] 
As-extruded pure Zn 32 61 3.5  [24] 
Minimum requirements of 
orthopedic implant 
230 300 15-18 7-30 [24, 25] 
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1.2. Absorbable osteosynthesis materials 
1.2.1. Bioresorbable polymers 
Currently, absorbable CMF osteosynthesis implants fabricated from polymeric 
materials, mainly polyglycolic acid (PGA) and polylactic acid (PLA) or their 
copolymers, have been used in the craniomaxillofacial surgery [5]. These 
polymers come from the poly (α-hydroxy acids) (HOCHR-COOH) family. The 
clinical application of biodegradable polymers as osteosynthesis implants was 
early reported in maxillofacial surgery in the 1970s [26, 27]. To date, 
bioresorbable polymeric osteosynthesis implants, such as mini-plates and screws, 
are used mainly in pediatric patients or in non-loading areas with 
craniomaxillofacial bone fracture, mainly because the bioresorbable materials do 
not hinder the facial growth [27]. Nonetheless, current polymeric materials are 
still considered insufficient for most routine clinical applications. 
In fact, principal limitations of polymeric osteosynthesis implants mainly include 
the poor mechanical strength, acidic degradation products and foreign body 
reactions, etc. [5, 27]. As shown in Table 1.1, it has been observed that the 
mechanical properties of bioresorbable polymers are significantly lower than 
those of metallic materials, indicating that the polymeric implants are insufficient 
for loading applications  [2]. Additionally, the ideal degradation process of 
implants demands that the degradation products can completely disappear in vivo 
and are replaced by the respective tissues. However, previous studies reported 
that polymeric implants might not completely be replaced by the bone tissue [28, 
29]. More importantly, a multicenter randomized controlled trial showed that the 
performance of biodegradable polymeric implants is inferior compared with that 
of titanium implants, causing high removal rates [30]. These disadvantages 
impede the wide application of polymeric osteosynthesis implants. 
1.2.2. Absorbable metals 
The term of absorbable metals (also named biodegradable metals) refers to 
metals that degrade safely within the body, mainly including magnesium (Mg), 
iron (Fe) zinc (Zn) and their alloys [7, 8, 19, 23, 31]. The generalized degradation 
mechanism is through a corrosion process in the specific physiological 
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environment. As depicted in Figure 1.1, an absorbable metal contact with human 
body fluid can trigger the anodic reaction. Simultaneously, the generated 
electrons can be consumed by the cathodic reaction, corresponding to the water 
reduction for Mg-based alloys and the dissolved oxygen reduction for Zn-based 
alloys and Fe-based alloys. A degradation product layer (Metal(OH)n) is formed 
on the surface through the reaction with the release of metal ions and hydroxide. 
With progressing degradation time, phosphate- and carbonate- based apatite can 
be further deposited onto the Metal(OH)n layer. In a physiological environment, 
the high concentration of chloride ions causes the breakdown of the degradation 
layers and accelerates the degradation process. According to the size of 
degradation particles, macrophages and/or fibrous tissue might enclose these 
degradation particles until the metal is completely degraded [7, 23]. 
  
Figure 1.1. Schematic diagram of the degradation mechanism of absorbable metals 
(own image). 
1.2.2.1. Magnesium-based osteosynthesis implants 
To date, research on the development of absorbable CMF osteosynthesis metals 
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has focused mostly on pure Mg and its alloys as a result of the excellent 
biocompatibility and mechanical properties [7, 8, 32]. As the main degradation 
product released from Mg-based alloys, the Mg ion is an essential mineral in the 
human body [7]. The elastic modulus of pure Mg is close to that of human cortical 
bone, probably preventing stress shielding, as shown in Table 1.1 [8, 19]. In fact, 
Mg-based osteosynthesis implants have been first proposed in 1900 [33]. 
However, lack of optimized corrosion behavior leads to rapid degradation of Mg-
based implants along with extensive subcutaneous gas cavities, causing local 
swelling and pain, which limited widely application until much later [33]. Recently, 
the corrosion resistance of Mg and its alloys could be increased by refinement 
technology. Although commercially available Mg-based osteosynthesis system 
has been approved, large-scale controlled clinical pilot trials of Mg alloys are still 
under way [34]. For the CMF applications reported, magnesium-based alloy 
osteosynthesis implants have been used in craniomaxillofacial surgery [35, 36]. 
Nevertheless, the intrinsic corrosion characteristics of Mg and its alloys provoke 
water reduction in a physiological environment (Figure 1.1), probably leading to 
the extensive accumulation of hydrogen. Accordingly, subcutaneous gas cavities 
might cause wound healing disorders. 
1.2.2.2. Iron-based osteosynthesis implants 
Pure Fe and its alloys exhibit high mechanical strength, as listed in Table 1.1 [23]. 
Importantly, ionic Fe is a human essential element and the main component of 
metallic proteins [37]. An early study reported the results of iron-based stents 
implanted into descending aortas of rabbits. No local and systemic toxicity was 
observed, suggesting an excellent biocompatibility [38]. Nevertheless, pure Fe 
and its alloys implanted into the femur of rats demonstrated that the implants 
degrade too slowly. Degradation products are observed for a long time in healed 
tissue, indicating that Fe-based osteosynthesis implants might be questionable 
[39]. Herein, numerous studies focused on accelerating the Fe/Fe alloy 
degradation process [40-42]. 
1.2.2.3. Zinc-based osteosynthesis implants 
Recently, Zn-based alloys have been considered as osteosynthesis materials 
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mainly due to the excellent in vivo biocompatibility, suitable mechanical properties 
and appropriate degradation behavior [43-47], Admittedly, ionic Zn has been 
described as the ‘calcium of the twenty-first century’ due to its significant 
functional roles in physiological and biological systems [48]. Also, Zn ions have a 
dual mode of action on bone formation and resorption through stimulating 
osteoblastogenesis and suppressing osteoclastogenesis [49]. In principle, Zn has 
a moderate corrosion behavior between those of Mg and Fe because the 
standard corrosion potential of Zn (-0.76 VSCE) is between Mg (-2.37 VSCE) and 
Fe (−0.44 VSCE) [23, 50, 51]. Importantly, a recent study reported that pure Zn 
stent was implanted into rabbit abdominal aorta for one-year, and Zn exhibited 
steady degradation behavior and its degradation products might be safely 
metabolized [52]. Similarly, Zn-based alloy pins implanted in mouse distal femurs 
can promote new bone formation [53]. Therefore, these advantages make Zn 
alloys potential materials as CMF osteosynthesis implants. 
1.3. Limitations at Zn-based CMF osteosynthesis implants 
1.3.1. Ideal criteria for CMF osteosynthesis materials 
Biocompatibility, biomechanics, biodegradability and biofunctionalization must be 
taken into consideration for the ideal osteosynthesis materials, as illustrated in 
Figure 1.2. Without a doubt, biocompatibility is an essential prerequisite for 
implant materials on cellular as well as tissue level. For bone applications, 
potential materials need to have sufficient strength to maintain mechanical 
support in the reconstruction process. For a biodegradable material, the 
candidate should degrade safely within the body and gradually lose its 
mechanical integrity while the bone tissue is regenerated. Ideally, released 
degradation products not only induce bone tissue formation but also prevent 
bacterial infection. 
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Figure 1.2. Key properties for ideal craniomaxillofacial osteosynthesis materials (own 
image). 
Considering the defined ideal criteria, Zn is not without its issues. Herein, Zn and 
its alloys as CMF osteosynthesis materials have been questionable, mainly 
including inconsistent biocompatibility results, relatively low mechanical 
properties, uncertain degradation behavior and ambiguous biofunctionalization. 
1.3.2. Biocompatibility 
Excellent biocompatibility is an essential prerequisite of Zn-based materials for 
clinical applications. Numerous previous studies demonstrated that pure Zn and 
its alloys implanted in vivo indicated no obvious local and systemic toxicity, the 
implantation sites included abdominal aorta [52, 54-63], subcutaneous [64-66] 
and bony environment [45, 53]. For the in vitro evaluation, the standardized 
cytotoxicity test, which evaluates the ability of a biomaterial to destroy living cells, 
is used to predict and screen the Zn biocompatibility. In these tests, an extract 
test is most frequently used to assess the toxicity of released degradation 
products [67]. Nevertheless, there are conflicting reports on the cytotoxicity 
results of Zn and its alloys. Obvious toxic effects of Zn and Zn-based alloys were 
observed in undiluted extracts [24, 68]. Thus, the inconsistent results between in 
vivo and in vitro biocompatibility tests can interfere with the fast development of 
novel Zn and its alloys. 
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1.3.3. Biomechanics 
Accurate mechanical property requirements specific for CMF osteosynthesis 
implants are still lacking, due to the diversity of clinical cases. Whereas, as a 
reference for craniomaxillofacial implants, absorbable orthopedic implants need 
to possess the minimum mechanical requirements of yield strength > 230 MPa, 
tensile strength > 300 MPa, and an elongation > 15-18% [24, 25]. As shown in 
Table 1.1, mechanical strength of pure Zn is lower than that of metallic implants 
and part of polymeric implants. It is indicated that relatively poor mechanical 
properties of Zn are insufficient to the biomechanics requirements of CMF 
osteosynthesis implants. Therefore, the first step of development and research 
of materials is to improve the mechanical strength of pure Zn, in order to meet 
the requirement of clinical application. In our previous work, a Zn-4Ag alloy and 
a Zn-2Ag-1.8Au-0.2V (wt%) alloy with high mechanical properties was developed 
and fabricated, which is sufficient for most clinical applications [69]. 
1.3.4. Biodegradability 
Biodegradability is a critical criterion for CMF osteosynthesis implants, which 
directly affects mechanical strength and even biocompatibility. An appropriate 
degradation behavior of implants determines the maintenance of mechanical 
integrity, and degradation products can directly influence the bone healing and 
remodeling [8, 23]. On the one hand, although previous outstanding studies have 
been performed to investigate the degradation mechanism of Zn in vivo, several 
aspects are not yet completely understood. For example, for osteosynthesis 
applications, it is uncertain whether the in vivo degradation rates of Zn-based 
alloys are suitable for the ideal degradation rates, e.g. 0.5 mm/year mentioned by 
[24]. On the other hand, buffered salt solutions like Hank's balanced salt solution 
have been most commonly used in previous in vitro corrosion tests, which can 
mimic in vivo physiological environment to only some extent. The influence of 
organic components such as serum on degradation behavior of Zn and its alloys 
remain obscure. 
1.3.5. Biofunctionalization 
Post-operative infection rates are up to 6.8% after CMF osteosynthesis 
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implantation [70]. Antibacterial properties of osteosynthesis implant materials 
could prevent post-operative infections. Theoretically, some metal ions such as 
Ag, Cu and Zn have been considered as antibacterial agents [71, 72]. Previous 
studies demonstrated that Zn-based alloys had effective antibacterial activity 
towards Staphylococcus aureus (S. aureus) [73, 74]. Nevertheless, an intraoral 
surgical approach is the increasing trend for treatment in maxillofacial trauma, 
indicating an increase in the risk with oral bacteria [75]. In other words, the 
antibacterial properties of a craniomaxillofacial biomaterial must be effective 
against related microorganisms. For most transcutaneous surgery, the organisms 
most likely to cause infection are S. aureus from the skin. However, for transoral 
maxillofacial surgery, the most microorganisms include Streptococci, anaerobic 
Gram-positive cocci and anaerobic Gram-negative rods [76]. Herein, considering 
Zn-based alloys as CMF osteosynthesis materials, the antibacterial properties 
should be evaluated by the related microorganisms, such as Streptococcus 
gordonii. 
Osteoinductivity refers to materials promoting the new bone formation. For 
physiological function, Zn ions play a significant role in bone formation, and they 
can not only stimulate bone growth and mineralization but preserve bone mass 
as well [77]. Admittedly, zinc-containing biomaterials such as zinc-based ceramic 
biomaterials also exhibited effects to promote new bone formation. The 
osteoinductivity of released Zn ions might be attributed to the inhibition of 
osteoclasts as well as the stimulation of osteoblastic differentiation [48, 49]. In 
addition, previous studies reported that Zn-based implants can induce new bone 
formation in vivo, implying the osteoinductivity of Zn-based alloys [53, 63]. 
Nonetheless, it is noteworthy to further investigate the effect of Zn degradation 
products on the adjacent cellular response, such as periosteal cells. 
1.4. Objectives 
Pure Zn provides principally an excellent biocompatibility and suitable 
degradation behavior observed in previous studies. Nevertheless, the 
mechanical properties of pure Zn are insufficient for osteosynthesis applications. 
Previously, we tested a newly developed Zn-4wt%Ag alloy with high strength [69]. 
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Therefore, the main objectives of the cumulative thesis include: 
1. To evaluate in vitro degradation behavior, cytotoxicity and antibacterial 
properties of a novel Zn-4wt%Ag alloy with high strength (Study I). 
2. To explore the effect of fetal bovine serum (FBS) on initial in vitro degradation 
behavior and the related cytotoxicity of Zn and its alloys (Study II). 
3. To investigate the influence of the degradation products of Zn and Zn-4Ag 
alloy on cytotoxicity and osteoinduction of human periosteal cells (Study III). 
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2. Study I: Mechanical characteristics, in vitro degradation, cytotoxicity, 
and antibacterial evaluation of Zn-4.0Ag alloy as a biodegradable 
material 
The part is a reprint of the following publication: 
Ping Li, Christine Schille, Ernst Schweizer, Frank Rupp, Alexander Heiss, Claudia 
Legner, Ulrich E. Klotz, Jürgen Geis-Gerstorfer, Lutz Scheideler. Mechanical 
characteristics, in vitro degradation, cytotoxicity, and antibacterial evaluation of 
Zn-4.0 Ag alloy as a biodegradable material. International journal of molecular 
sciences, (2018) 19(3), 755. 
Abstract: 
Zn-based biodegradable metallic materials have been regarded as new potential 
biomaterials for use as biodegradable implants, mainly because of the ideal 
degradation rate compared with those of Mg-based alloys and Fe-based alloys. 
In this study, we developed and investigated a novel Zn-4 wt% Ag alloy as a 
potential biodegradable metal. A thermomechanical treatment was applied to 
refine the microstructure and, consequently, to improve the mechanical 
properties, compared to pure Zn. The yield strength (YS), ultimate tensile strength 
(UTS) and elongation of the Zn-4Ag alloy are 157 MPa, 261 MPa, and 37%, 
respectively. The corrosion rate of Zn-4Ag calculated from released Zn ions in 
DMEM extracts is approximately 10.75 ± 0.16 μg cm-2 day-1, which is higher than 
that of pure Zn. In vitro cytotoxicity tests showed that the Zn-4Ag alloy exhibits 
acceptable toxicity to L929 and Saos-2 cells, and could effectively inhibit initial 
bacteria adhesion. This study shows that the Zn-4Ag exhibits excellent 
mechanical properties, predictable degradation behavior, acceptable 
biocompatibility, and effective antibacterial properties, which make it a candidate 
biodegradable material. 
2.1. Introduction 
Biodegradable metals (BMs) are regarded as the next revolutionary metallic 
biomaterials and have become a potential alternative to permanent biomaterials 
during the last decade [23, 51, 78]. Magnesium, iron, zinc and their related alloys 
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have been intensively investigated for their potential as BMs. However, the rapid 
corrosion rate accompanied by the accumulation of hydrogen in physiological 
environment impedes the clinical application of Mg-based alloys [79, 80]. Fe-
based alloys, on the contrary, exhibit relatively slow degradation rates and 
excellent mechanical properties, but superior corrosion resistance may impede 
the desired replacement by newly formed tissue [81, 82]. 
In comparison with Mg and Fe, the standard corrosion potential of Zn (−0.762 
VSCE) is between Fe (−0.440 VSCE) and Mg (−2.372 VSCE) [23, 50, 51]. Bowen et 
al. [55] reported the biocompatibility and degradation of zinc wires implanted into 
the abdominal aorta of rats, and zinc wires exhibited moderate degradation rates 
in vivo for up to 6.5 months. Moreover, zinc is one of the essential nutrients in the 
human body, where it influences various normal physiological processes [83, 84]. 
Additionally, considering bio-safety, the recommended allowances for zinc 
element are estimated at 15 mg day-1 [23]. Besides its excellent corrosion and 
biocompatibility properties, Zn is also one of only a few metals with high magnetic 
resonance imaging compatibility, which is superior to that of Mg alloys and Fe 
alloys. The magnetic (volume) susceptibility of Zn, Mg and Fe are −15.7 × 106, 
+11.7 × 106 and +0.2 × 106, respectively [85]. Therefore, these advantages make 
Zn-based alloys promising candidates for a new generation of BMs, especially 
for use as osteosynthesis materials and cardiovascular stents [43, 55]. 
Regarding the clinical requirements, the application of pure Zn in BMs is limited 
because of its weak strength, plasticity, and hardness. It has been investigated 
that the tensile strength of pure Zn is from 10 MPa to 110 MPa, the elongation is 
0.32% to 36%, and the Vickers hardness is 38 HV1 to 39 HV1, being insufficient 
mechanical properties for most clinical applications [43, 86]. Thus, biodegradable 
Zn-based alloys with superior mechanical properties should be developed to 
meet the clinical requirements. Improvements in mechanical properties may be 
achieved by adding alloying elements and/or appropriate thermomechanical 
treatment such as extrusion, rolling, forging, annealing and so forth [87, 88]. In 
BMs, the biocompatibility of alloying elements must be carefully considered. In 
this work, Ag is proposed as an alloying element in Zn-based alloys, which could 
improve mechanical properties. According to the phase diagram (Figure 2.1) up 
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to 6 weight% Ag is solvable in Zn at temperatures of about 400 °C. As the 
solubility decreases upon cooling, ε-AgZn3 precipitates form. Thus, dislocations 
are pinned by the precipitates resulting in improved hardness and strength 
(precipitation hardening). Zn-Ag binary alloys have been investigated and Ag has 
been proven to effectively improve the mechanical properties efficiently [89]. 
Moreover, the Ag ion shows antibacterial functions and has already been used 
as alloying element [90]. Adding Ag has shown promising antibacterial properties 
in Mg-based alloys while preserving the biocompatibility [90]. 
 
Figure 2.1. (a) Calculated Zn-Ag phase diagram using the Themo-Calc software and the 
SNOB-3 database. (b) Detail of the phase diagram (a) manifesting that up to 6 wt% Ag 
can be solved in Zn. Upon cooling the composition enters the two-phase area, i.e. 
precipitations of ε-AgZn3 in the Zn matrix occur. As this effect is generally accompanied 
by an increase in strength, it referred to as precipitation hardening. 
In this study, the aim was to develop and investigate a Zn-4wt%Ag alloy as a 
novel biodegradable metal. The Zn-4Ag alloy was prepared, and 
thermomechanical treatment was applied to refine the microstructure and 
improve the mechanical properties. The microstructure, mechanical properties 
and corrosion behavior of the Zn-4Ag alloy were investigated. Furthermore, the 
cytotoxicity and antibacterial properties were also evaluated. 
2.2. Materials and methods  
2.2.1. Materials preparation  
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Alloys were prepared from high purity elements (> 99.9%) by induction melting 
(Indutherm VC 500 D, Germany) under 1 bar Argon in a graphite crucible. An 
oxide scavenger (Zincrex D85, Feuerungsbau Mutschler GmbH, Germany) was 
employed to clear the melt. The melt (750 °C) was cast into a cylindrical graphite 
mold of 15 mm diameter. During solidification the mold was vibrated resulting in 
a reduction in grain size from approximately 200 µm to about one tenth this size. 
All casting rods were homogenized at 300 °C for 1 h in a furnace under Ar 
protective gas and then left in the furnace for cooling. The moderate cooling rate 
allowed phase separation and grain growth which proved to be advantageous for 
the subsequent hot working. The rods were first machined to diameter of 10 mm 
and then swaged to 3 mm diameter wires. As the rods proved to be too brittle for 
swaging at room temperature, rods and tool were preheated to 200 °C. 
Subsequently, the wires were annealed at 390 °C for 15 minutes, quenched in 
water and finally precipitation hardened in an oil bath for 10 minutes at 100 °C. 
An inductively coupled plasma optical emission spectrometry (ICP-OES) analysis 
of the alloy confirmed composition.  
For the corrosion tests and the biological tests, small plates with a dimension of 
(7 × 7 × 0.5) mm3 were prepared analogously to the wires by casting into a 
rectangular graphite mold with a thickness of 10 mm, homogenization at 300 °C 
for 1 h, hot rolling at 200 °C, annealing at 390 °C for 15 minutes and finally cutting. 
Samples were ground with SIC paper of P1200 (Buehler-Wirtz, Düsseldorf, 
Germany) using a grinding machine (Meta Serv, Buehler-Wirtz, Düsseldorf, 
Germany) and ultrasonically cleaned (Sonorex super RK102H, Bandelin, Berlin, 
Germany) with absolute ethanol for 10 min. Each side of the specimens was 
further sterilized by ultraviolet-radiation for at least 1 h in a sterile workbench 
(Lamin Air HB2472, Heraeus, Hanau, Germany) for corrosion test, cytotoxicity 
and antibacterial evaluation. 
2.2.2. Microstructure observation and mechanical characteristic test 
Metallographic cross sections of each processing step were prepared, etched 
with 2% Nital, a mixture of EtOH and HNO3, and routinely subjected to a light 
microscopic investigation (Zeiss Axioplan 2, Germany). Vickers hardness 
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(diamond pyramid hardness), here denoted as HV1, was measured on 
metallographically polished cross sections using a load of 1 kg. Hardness is 
generally proportional to ultimate tensile strength (UTS) values, but it does not 
provide information about the ductility of alloy. 3 mm wires were subjected to 
tensile testing according to DIN EN ISO 10002-1 in a Zwick Z100HT universal 
testing machine (Zwick, GmbH, Germany) at a room temperature. The strain was 
measured until fracture using a strain gauge on a starting length of 15 mm. The 
testing speed was 1.5 mm/min until the yield strength was surpassed and then 
increased to a strain controlled strain rate of 0.0025 s-1. The values for 0.2% yield 
strength (YS0.2), ultimate tensile strength (UTS) and elongation (εf) were 
determined. 
Prior to an investigation in the scanning electron microscope (SEM), all cross 
sections were subjected to an broad argon ion beam polishing procedure (BIB, 
sample rotation, 3° incident angle, 6 kV, 2.2 mA, 15 cycles: 2 min beam on, 15 
min rest) using a Bal-Tec RES 101 (now Leica Microsystems GmbH, Germany). 
The SEM investigations were conducted with a Zeiss Auriga 60 (Carl Zeiss 
Microscopy GmbH, Germany) equipped with a field emission gun and a 80 mm2 
SDD EDX-Detector (X-Max 80, Oxford Instruments, UK). 
A Bruker D8 GADDS diffractometer (Bruker AXS GmbH, Germany) equipped with 
a Våntec-500 2D detector (Bruker AXS) was employed for X-ray diffraction (XRD) 
based phase analysis. The x-ray beam (λ(Cu Kα) = 1.54 Å) was adjusted using a 
Göbel mirror and a 1 mm collimator. Acquired diffraction rings were translated (by 
integration) to 1 dimensional diffraction pattern using the GADDS and MERGE 
software packages. Pattern analysis relied on the software DIFFRAC.EVA 2 
(Bruker) and the database (ICDD-PDF-2). 
2.2.3. Extracts preparation  
The extracts of Zn-4Ag alloy and pure Zn were prepared in DMEM (Dulbecco's 
modified Eagle medium; Gibco-Life Technologies, Gaithersburg, MD, USA) 
containing 10% fetal calf serum (FCS; PAA Lab, GmbH, Linz, Austria), 1% 200 
mM L-glutamine (PAA Labor GmbH, Linz, Austria), and 1% penicillin 10 mg/ml 
(Gibco-Life Technologies, Darmstadt, Germany) and McCoy's 5A (Sigma-Aldrich 
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Chemie GmbH, Steinheim, Germany) supplemented with 15% FCS , 1% 200 mM 
L-glutamine and 1% penicillin 10 mg/ml at 37 °C in 5% CO2 for 24 h. The ratio of 
surface area (cm2) to solution volume (ml) was set to 3 cm2 ml-1 for all samples, 
according to ISO 10993-12:2012 [91]. Thereafter, series of dilution of the extracts 
were performed with four extract concentrations, namely 10% extracts (dilution 
factor 1 : 10), 16.7% extracts (dilution factor 1 : 6), 33.3% extracts (dilution factor 
1 : 3) and 100% extracts, according to the recommendation in Ref [92]. The 
extracts were further used for corrosion rate determination and cytotoxicity 
evaluation. 
2.2.4. Corrosion rate determination 
The estimated corrosion rates were calculated from released ions in the extracts 
according to the previous studies [93-95]. An ICP-OES (Optima 4300 DV, Perkin 
Elmer, Rodgau, Germany) was employed to detect released Zn and Ag ions in 
the extracts. Measured extracts were diluted triple prior to the measurement. 
Released Zn and Ag ions were measured at 2 different wavelengths with three-
time repetition. The corrosion rate was calculated from released Zn ions using 
the following formula, according to the Ref [96]: 
Corrosion rate (μg cm-2 day-1) = (C × V) / (S × T) (1) 
where C is the released Zn ions concentration in μg/ml, V is the solution volume 
in ml, S is the sample surface area in cm2, T is the incubation time in days. The 
surface morphology and chemical composition of the corrosion products on the 
surfaces after immersion were also observed using a scanning electron 
microscope equipped with an energy dispersive X-ray spectrometer (SEM-EDX; 
LEO 1430, Zeiss, Oberkochen, Germany). 
2.2.5. Cytotoxicity tests 
The cytotoxicity evaluation of Zn-4Ag was performed via extract test, according 
to ISO 10993–5: 2009 [97]. L929 fibroblasts (Mouse fibroblast cell line, DSMZ 
GmbH, Braunschweig, Germany) and Saos-2 osteoblasts (Human primary 
osteosarcoma cell line, DSMZ GmbH, Braunschweig, Germany) were used. 
Cytotoxicity was tested for two biological endpoints: metabolic activity (Roche 
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Cell Proliferation Kit II, XTT assay) and cell proliferation (Roche cell proliferation 
ELISA, BrdU assay). Ti-6Al-4V alloy (Camlog, Wimsheim, Germany) was used 
as negative control. L929 fibroblasts were cultured in 24 ml DMEM medium and 
Saos-2 osteoblasts were cultured in 10 ml McCoy's 5A. Both cell types were 
grown in 75 cm2 culture flasks (Costar, Corning, Tewksbury, MA, USA) at 37 °C 
in a humidified atmosphere of 5% CO2. 
For the tests, L929 fibroblasts and Saos-2 osteoblasts were seeded in 96-well 
plates (200 μl/well) at a cell density of 1 × 104 cells per well and pre-incubated 
overnight. Thereafter, 150 μl of the respective extract dilutions replaced the cell 
medium (4 parallel wells per dilution). After 24 h incubation with these extracts, 
50 μl XTT reagent was added to each well for 2 h. Subsequently, the formazan 
formation was determined photometrically using an ELISA Reader (Biotek, Bad 
Friedrichshall, Germany) at the wavelengths of 450/620 nm. Proliferative activity 
of L929 and Saos-2 was determined in the logarithmic growth phase between 24 
h and 48 h after seeding by BrdU assay. 15 μl BrdU labeling reagent were added 
to each well 24 h after seeding. Additional cell cultures without BrdU-label were 
used as background controls. Culture medium without cells containing BrdU and 
Anti-BrdU-POD was used as blank controls. Afterwards, the cells were fixed, and 
Anti-BrdU-POD was added according to manufacturer's instructions. The 
absorbance of the samples was measured using an ELISA Reader at 450/690 
nm. 
2.2.6. Antibacterial effect evaluation 
For determining bacterial adhesion, Zn-4Ag samples were inoculated with 
Streptococcus gordonii strain DL1 (S. gordonii) and adhering bacteria were 
determined using a crystal violet staining assay (0.5% crystal violet in 20% 
methanol) and a green fluorescent nucleic acid stain (Live/Dead BacLight 
Bacterial Viability Kit, Invitrogen, L13152, USA). Bacteria were grown as a 
stationary suspension culture in Schaedler medium (Beckton Dickinson GmbH, 
Heidelberg, Germany) overnight at 37 °C. Thereafter, 4 ml S. gordonii suspension 
were added to each sample in 6-well plates and cultivated for 12 h at 37 °C. After 
incubation for 12 h, S. gordonii suspension was carefully removed and samples 
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were immersed in 3 ml crystal violet solution for 20 min. After staining, the 
samples were rinsed 3 times with deionized water. Subsequently, the samples 
were observed and photo-documented under a photomacroscope (Wild M 400, 
Wild, Heerbrugg, Switzerland) equipped with a remote control DSLR (Nikon 550D, 
Japan). For live/dead test, the samples were rinsed two times with Hanks' salt 
solution (Biochrom AG, Germany). Live/dead staining was used to evaluate the 
live/dead state of bacteria on the surface, following the manufacturer's 
instructions. The biofilm formation and adherent bacteria were examined with a 
fluorescence microscope (Optiphot-2, Nikon, Tokyo, Japan) equipped with a 
remote control DSLR. Ti-6Al-4V samples were selected as a reference. 
2.2.7. Statistical methods 
The inhibition of metabolic activity of the cells (XTT) was determined in three 
independent experiments, and the proliferation tests (BrdU-incorporation) were 
performed twice. The combined results of the respective cytotoxicity tests are 
given as mean values ± standard deviation. Statistical significance of differences 
between groups was tested by Student's t-test. Differences of p-values < 0.05 
were considered statistically significant. 
2.3. Results and discussion  
2.3.1. Microstructure and mechanical properties 
The evolution of microstructure was investigated by light and scanning electron 
microscopy. A heat treatment (homogenization, 300 °C for 1h) induced a 
transformation of the dendritic as-cast microstructure (Figure 2.2a) to large 
globular grains. After the thermomechanical treatment, i.e. swaging, annealing 
(390 °C for 15 min) and quenching, bright grains corresponding to the ε-AgZn3 
phase are visible (Figure 2.2b). Subsequent precipitation hardening (100 °C for 
10 min) led only to slightly larger grains but did not further affect the 
microstructure (Figure 2.2c). 
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Figure 2.2. Optical micrograph of (a) the as-cast Zn-4Ag dendritic microstructure. (b) 
Longitudinal sections after thermomechanical treatment (homogenization, swaging and 
solution annealing) and after (c) precipitation hardening showing globular grains. Large 
ε-AgZn3 grains (bright) can be identified on the cross sections. 
Table 2.1. Assessment of mechanical properties by tensile testing and Vickers hardness 
tests. 
Alloy / processing 
Mechanical Properties 
References 
Yield 
Strength  
(YS0.2) 
(MPa) 
Ultimate 
Tensile 
Strength 
(UTS) (MPa) 
Elongation to 
failure (%) 
Hardness 
(HV1) 
Zn-4Ag* 157 261 37 73 In this study 
Zn-4Ag** 149 215 24 82 In this study 
WE43 / extruded 195 280 10 - [98] 
Zn / cast 10 18 0.32 38 [51] 
Zn / extruded 35 60 3.5 - [51] 
Zn / hot rolled 30-110 50-140 5.8-36 39 [51] 
Zn-2.5Ag / extruded 147 203 35 - [89, 99] 
Zn-5Ag / extruded 205 253 36 - [89, 99] 
Zn-7Ag / extruded 236 287 32 - [89] 
* Thermomechanical treatment; ** Additional precipitation hardening. While the aspired 
precipitation hardening essentially resulted only in a slight increase in hardness, yield 
strength and ultimate tensile tended to decrease. This is due to the fact that that 
precipitates had formed beforehand (see next paragraphs). 
Concerning thermomechanical treatment and precipitation hardening, the 
resulting mechanical properties are compiled in Table 2.1. A minor modification 
of the Mg alloy WE43 is already used for bioresorbable stents. The material 
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exhibits reasonable mechanical properties, but the corrosion rate is high, a 
controversial issue among experts [100]. Bowen et al. [54] investigated the 
qualification of metallic zinc for bioresorbable stents. They concluded that the 
comparably slow corrosion rate and the low toxicity of the resulting products make 
zinc a promising candidate for bioresorbable stents. However, the authors 
acknowledge the insufficient mechanical properties of pure zinc, exluding a 
straight-forward application, and discuss putative additives. A recent publication 
shows that the addition of Ag results in considerably improved mechanical 
properties [89], which is in good agreement with the data presented here. Zn-4Ag 
shows good mechanical properties. Subsequent precipitation hardening (100 °C 
for 10 min) did not improve the mechanical properties. While the hardness slightly 
increases, YS und UTS both slightly decrease. This minor loss of strength is 
probably due to grain growth. Nevertheless, a sufficiently large window between 
YS (157 MPa) and UTS (261 MPa) as well as an elongation of 37% represents 
an excellent starting point for future material developments. 
The missing aging effect of this heat treatment might be explained by the fact that 
the precipitates predominantly had formed beforehand. XRD analysis of the 
thermomechanically treated state confirmed the presence of the two expected 
phases, Zn and ε-AgZn3 (Figure 2.3). 
A micrograph acquired by surface sensitive secondary electron (SE) imaging at 
an accelerating voltage of 6 kV is shown in Figure 2.4a. Despite the gentle BIB 
polishing procedure, the surface is characterized by a certain grain orientation 
dependent topography and surface roughness, respectively. Submicron sized, 
Ag enriched ε-AgZn3 particles were identified along the Zn grain boundaries by 
EDX mapping (Figure 2.4a, blue colouring). Nucleation and growth of the ε-AgZn3 
particles led on the other hand to a Ag depleted zone. Moreover, small 
precipitates inside the Zn grains were detected by backscatter electron imaging 
(BSE) at 20 kV (Figure 2.4b). 
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Figure 2.3. XRD pattern (black) of Zn-4Ag after thermomechanical treatment. The 
phases Zn (03-065-3358, blue) and ε-AgZn3 (00-025-1325, orange) were identified. 
 
Figure 2.4. SEM investigation of the microstructure after thermomechanical treatment. 
(a) For the sake of resolution, SE imaging of the BIB polished surface as well as the 
corresponding EDX analysis were performed at 6 kV. The overlay shows that ε-AgZn3 
particles have formed along the grain boundaries while the proximity is Ag depleted. (b) 
20 kV BSE imaging revealed the presence of ε-AgZn3 precipitates within the Zn grains. 
2.3.2. Corrosion properties 
In this study, corrosion rates of Zn-4Ag alloy and pure Zn were calculated from 
released Zn ions in the cell medium extracts (Figure 2.5), which correspond to 
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the cytotoxicity of the Zn-4Ag alloy and pure Zn. The cell media used, DMEM and 
McCoy's 5A, consist both of inorganic ions and organic components with 
concentrations equal to those in human plasma, as shown in Table 2.2. The use 
of extraction media with concentrations of buffering agents and glucose similar to 
those of human plasma is critical for predicting in vivo corrosion rate [101]. In 
these tests using cell culture medium instead of simple salt solutions, the extract 
conditions are more closely related to the physiological environment in the body, 
although extraction time is only for 24 h. However, in vitro corrosion rates from 
long-term immersion tests in simulated body fluid should be further investigated. 
 
Figure 2.5. Corrosion rates of pure Zn and Zn-4Ag in DMEM and McCoy's 5A calculated 
from released Zn ions.  
As shown in Figure 2.5, corrosion rates of Zn-4Ag in DMEM and McCoy's 5A 
were (10.75 ± 0.16) μg cm-2 day-1 and (3.80 ± 0.14) μg cm-2 day-1, respectively, 
which is higher than the counterpart of pure Zn, (6.85 ± 0.02) μg cm-2 day-1 and 
(2.89 ± 0.08) μg cm-2 day-1. It is clearly evident that higher corrosion rates in 
DMEM in comparison to McCoy's 5A were also observed. The difference can be 
ascribed to the different composition of DMEM and McCoy's 5A. One reason 
could be the higher (15%) concentration of FCS which was used in McCoy's 5A. 
It is known that the proteins in FCS can decrease corrosion rates, which was also 
observed in the case of Mg alloys [102]. 
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Table 2.2. Composition of the blood plasma, DMEM and McCoy's 5A [101, 103, 104] . 
 Blood plasma DMEM McCoy’s 5A 
Inorganic ions (mmol l-1) 
Na 142 127.3 141.0 
K 5.0 5.3 5.4 
Mg 1.5 0.8 0.8 
Cl 103.0 90.8 117.2 
Ca 2.5 1.8 1.2 
HPO4 1.0 0.9 4.2 
SO4 0.5 0.8 0.8 
HCO3 27.0 44.1 26.2 
Organic components 
Protein (g l-1) 63-80 - - 
Glucose (mmol l-1) 3.6-5.2 4.5 16.6 
Amino acids (g l-1) Variable 1.6 0.4 
Concentrations of buffering 
agents (mmol l-1) 43.5-45.5 70 30.4 
In most previous studies, in vivo corrosion rates of Zn alloys were estimated by 
in vitro long-term immersion tests and electrochemical tests [51, 103]. However, 
standardized in vitro methods for the corrosion rate determination which are able 
to mimic the degradation behavior of Zn alloys in the complex body physiologic 
environment are still lacking. In this study, the in vitro corrosion rate determination 
of Zn alloys was estimated from released Zn ions in DMEM for 24 h, as reported 
in previous studies [93-95]. Kubásek et al. [93] reported the corrosion rate of Zn-
0.8Mg in DMEM was (13.4 ± 0.3) μg cm-2 day-1. This value is close to the 
calculated value of (10.75 ± 0.16) μg cm-2 day-1 in our present study. Jablonská 
et al. [94] reported a corrosion rate of Zn-1.5Mg calculated by released ions in 
extracts of (52 ± 10) μg cm-2 day−1 for an untreated control under a CO2 
atmosphere, which is higher than the corrosion rate of Zn-4Ag in our study. The 
difference could be attributed to a different surface to volume ratio in the two 
studies and the fact that in the study of Jablonská et al. the solid corrosion 
products were dissolved by addition of ultrapure HNO3 prior to determination of 
the released ions. 
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In our study, adding Ag as alloying element to pure-Zn clearly increased the 
corrosion rate of the Zn-Ag binary alloy, which is consistent with previous findings 
[89]. Sikora-Jasinska et al. [89] reported that the corrosion rates of Zn-2.5Ag, Zn-
5.0Ag and Zn-7.0Ag alloys are from 79 to 84 μm year−1 in Hanks' modified 
solution, which is higher in comparison to pure Zn. This might be related to the 
formation of the ε-AgZn3 phase, inducing micro-galvanic corrosion, which finally 
leads to a decreased corrosion resistance of Zn-Ag alloys. 
 
Figure 2.6. The SEM-EDX analysis of the Zn-4Ag alloy after immersion in DMEM / 
McCoy's 5A for 24 h: (a) SEM images of Zn-4Ag alloy in DMEM (magnification 1000×), 
(b) EDX result of the degradation products in (a), (c) SEM images of Zn-4Ag alloy in 
McCoy's 5A (magnification 1000×), (d) EDX result of the degradation products in (c). 
Figure 2.6 shows the surface morphologies detected by SEM and the EDX 
analyses of corrosion products on the surface of Zn-Ag alloy after immersion for 
24 h. The degradation products of Zn-4Ag were mainly similar as those of pure 
Zn. Only a small amount of white degradation products were distributed on the 
surface, and round particles formed on the surface were observed at high 
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magnification (Figure 2.6a and Figure 2.6c), which is consistent with previous 
studies [89, 105]. The EDX analysis (Figure 2.6b and Figure 2.6d) shows that 
these degradation products of Zn-4Ag alloy were mainly composed of Zn, O, P, 
C and Cl, suggesting that these particles could be mainly composed of 
hydroxides, phosphate, carbonate compounds and chloride salt formation, as 
reported in previous studies [43, 88, 106]. 
2.3.3. Cytocompatibility 
Table 2.3 shows the mean Zn ion concentration after incubation of pure Zn and 
Zn-4Ag alloy in DMEM / McCoy's 5A to correlate the ion concentrations to the 
results of the cytotoxicity tests (Figure 2.7 and Figure 2.8). Analysis of the mean 
Zn ion concentration revealed that the highest concentration was determined for 
Zn-4Ag alloy of 100% extract in DMEM with 493.4 μM. Furthermore, the mean 
Zn ion concentration in DMEM extracts is higher than the counterpart in McCoy's 
5A. In addition, the mean Ag ion concentration in Zn-4Ag extracts was below the 
detection limit of the instrument, indicating a very limited release of Ag element 
into cell medium, although some Ag ions may be bound in the corrosion products. 
Table 2.3. The mean Zn ion concentration in pure Zn and Zn-4Ag alloy extracts. 
Cell medium Samples 
Zn ion concentration (μmol/l) 
100% 
extracts 
33.3% 
extracts 
16.7% 
extracts 
10% 
extracts 
DMEM 
Pure Zn 314.4 107.4 55.5 34.7 
Zn-4Ag 493.4 167.2 85.4 52.6 
McCoy’s 5A 
Pure Zn 132.8 51.5 31.1 22.9 
Zn-4Ag 174.4 65.4 38.0 27.0 
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Figure 2.7. Effect of different concentrations of Zn-4Ag alloy and pure Zn extracts on the 
cell metabolic activity of L929 and Saos-2 determined by XTT assay. Ti-6Al-4V alloy was 
used as negative control and was set to 100%. Means of three independent experiments 
are shown with respective standard deviations. 
Figure 2.7 shows the metabolic activity of L929 and Saos-2, respectively, cultured 
in 100%, 33.3%, 16.7% and 10% extracts of Zn-4Ag for 24 h; pure Zn served as 
a control. According to ISO 10993-5: 2009, a decrease of cell viability higher than 
30% is considered as a toxic effect. For the Zn-4Ag alloy, L929 cells and Saos-2 
cells cultured in 100% Zn-4Ag extracts showed a much lower metabolic activity, 
below 40% of the control. Thus, these undiluted extracts possess clearly 
cytotoxicity. In the 33% Zn-4Ag extract, the cell viability of Saos-2 already 
approached 100%. L929 cells, on the contrary, reached approximately 40%. For 
10% and 16.7% diluted extracts of Zn-4Ag, the metabolic activities of L929 cells 
and Saos-2 cells were always reaching 100%, and there was no statistically 
significant difference between Zn and Zn-4Ag groups (p > 0.05). Therefore, the 
Zn-4Ag alloy tested showed a certain degree of toxicity for L929 cells and Saos-
2 cells based on the cytotoxicity results in our test systems. 
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Figure 2.8. Influence of different concentrations of Zn-4Ag alloy and pure Zn extracts on 
the cell proliferation of L929 and Saos-2 determined by BrdU assay. Ti-6Al-4V alloy was 
used as negative control and was set to 100%. Means of two independent experiments 
are shown with respective standard deviations. 
Figure 2.8 shows the cell proliferation of L929 cells and Saos-2 cells cultured in 
100%, 33.3%, 16.7% and 10% extracts of Zn-4Ag and pure-Zn for 24 h 
determined by BrdU incorporation. In vitro cytotoxicity can be easily evaluated 
with tetrazolium-salt-based assays. However, XTT assay and Cell Counting Kit-
8 (CCK-8; Dojindo Molecular Technologies, Kumamoto, Japan) in our preliminary 
experiments were influenced by the degradation products of Zn-based alloys , for 
reasons which are probably similar to Mg-based alloys [107]. In contrast to the 
tetrazolium-salt-based XTT-assay, the BrdU incorporation is a direct measure for 
proliferative activity. An additional advantage is that the BrdU assay is not prone 
to the interference of the released Zn ions with tetrazolium-based assays [107] . 
In 100% extracts of Zn-4Ag alloy and pure Zn, both cell types showed an almost 
total inhibition at proliferation ability, which was different compared to the results 
of the metabolic activity. In different diluted extracts of Zn-4Ag alloy and pure Zn, 
the proliferation activities of L929 and Saos-2 exhibited similar results as with the 
metabolic activities. 
As a potential biodegradable material, the biocompatibility of the degradable Zn-
4Ag alloy should be considered. In fact, the significance of Zn in human nutrition 
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has been widely acknowledged. Zn is the second most abundant transition metal 
in the human body and an essential element for numerous biological functions 
[108, 109]. The recommended intake for an adult is estimated at 15 mg day−1 [23, 
51]. Also, the human tolerance level silver is estimated from 0.4 μg day−1 to 27 
μg day−1 [110]. The effects evaluated by the extract test for the biodegradable 
Zn-based alloy is mainly attributed to the released corrosion products during the 
degradation process. In this study, a considerable released Zn ion concentration 
in extracts was found, while the Ag ion concentration was below the detection 
limit, indicating that the Zn ion concentration mainly determined the toxicity of the 
Zn-4Ag alloy. As far as systemic toxicity is concerned, the daily released Zn ions 
of the Zn-4Ag alloy are far below the above-allowed value. With the Zn ion 
concentration decreased in the diluted extracts, the cytotoxic effect also 
decreased, which is consistent with several studies [111, 112]. It is worth noting 
that significant differences in Zn ion concentrations were determined between 
both cell media under the same extraction conditions, which is obviously 
related to the different composition of the media.  
Concerning cell sensitivity to zinc, Kubásek et al. [93] reported the Zn2+ safety 
concentrations for L929 and U-2 OS cell being 80 μM and 120 μM, respectively. 
In this present work, results similar to the above study were found. The mean Zn 
ion concentrations in 100% Zn-4Ag extract of DMEM and McCoy's 5A were 493.4 
μM and 174.4 μM, respectively. These values are higher than the safety 
concentrations. In our study, metabolic activity, determined by XTT assay, was 
less decreased by cytotoxic effects of the experimental alloy than proliferation 
determined by BrdU assay. This may be caused by the fact that metabolic activity 
of the cells is less sensitive to the cytotoxic action of the released Zn ions. 
However, interference of these ions with tetrazolium salts in the XTT assay may 
contribute this effect. 
For extract tests, most studies have found that only diluted extracts of 
biodegradable Zn-based alloys exhibited good cell viability [50, 88, 93], although 
even undiluted extracts have shown no cell toxicity in few studies [87, 113]. The 
difference observed might be caused by different cell lines and different 
experimental Zn-based alloys. It is already been discussed that the current ISO 
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10993 standards for in vitro cytotoxicity tests (10993-5: 2009 and 10993-12: 2012) 
have only limited value for the evaluation of biodegradable metallic materials [91, 
97]. Wang et al. [92] suggested that a maximal tenfold dilution (10% extracts) to 
a minimal sixfold dilution (16.7% extracts) of extracts for in vitro cytotoxicity tests 
were recommended for screening potential Mg-based alloys. According to this 
suggestion, the Zn-4Ag alloy in this study would have no potential cytotoxicity, 
according to the results of the 10% and 16.7% extracts. However, it is critical to 
perform in vivo systematic toxicity evaluation in future studies. 
2.4.4 Antibacterial evaluation 
The antibacterial properties of Zn-4Ag alloy to inhibit biofilm formation and initial 
bacterial adhesion was evaluated by crystal violet staining and live/dead staining, 
as shown in Figure 2.9 After 12 h incubation with S. gordonii, the surface of the 
Ti-6Al-4V alloy showed an intense violet staining and green fluorescence (Figure 
2.9a and Figure 2.9b), respectively, which means a high level of biofilm formation 
and a significant amount of adherent S. gordonii. In comparison, Zn-4Ag alloy 
presented point-like violet staining and a thin layer of green fluorescent vital 
bacterial chains (Figure 2.9c and Figure 2.9d), indicating the inhibition of initial S. 
gordonii adhesion and less biofilm formation compared with the Ti-6Al-4V alloy. 
Postoperative infection is a common complication in surgical implants, and the 
infection rate ranges from 1% to 4.5% for dental implant surgery [114]. The 
postoperative infection not only leads to implants failure but also delays tissue 
remodeling. In the present work, Zn-4Ag alloy could effectively inhibit bacterial 
adhesion and biofilm formation in comparison to Ti-6Al-4V alloy, indicating a good 
antibacterial effect. It is well known that Zn and Ag ions possess excellent 
antibacterial functions, and especially Ag has been used as effective antimicrobial 
agents incorporated into all kinds of biomaterials, such as metals, polymers, 
ceramics and glasses [115, 116]. The exact mechanism of Zn and Ag action on 
bacteria has not been completely understood but may probably include 
interference with electron transport binding to DNA and interaction with the 
membrane [115, 117]. Hu et al. [118] reported that Zn-incorporated TiO2 coatings 
on titanium by plasma electrolytic oxidation could greatly inhibit the growth of both 
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Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Moreover, the 
antibacterial effects of Ag ions in biodegradable Mg-Ag alloys have also been 
studied. Increased Ag addition (from 2% to 6%) showed a 74% to 79% reduction 
of bacterial viability and a 50% to 75% reduction of adherent bacteria [90]. 
Therefore, the novel developed Zn-4Ag alloy could prevent or at least diminish 
postoperative infection. 
 
Figure 2.9. Biofilm formation and initial bacterial adhesion on Ti-6Al-4V alloy (a,b) and 
Zn-4Ag alloy (c,d) after incubation with S. gordonii for 12 h. a and c by crystal violet 
staining (magnification 32×); b and d by live/dead staining (magnification 400×). 
2.4. Conclusions 
A Zn-4Ag alloy was developed as a novel biodegradable Zn-based alloy, and 
thermal treatment was applied to improve its mechanical properties and to refine 
the microstructure. The in vitro degradation behavior, cytotoxicity and 
antibacterial evaluation were also investigated. Based on the limitations of the in 
vitro study, the following conclusions can be drawn: 
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1. After thermomechanical treatment, the yield strength (YS), ultimate tensile 
strength (UTS) and elongation of the alloy are 157 MPa, 261 MPa and 37%, 
respectively, rendering this alloy a promising material for bioresorbable stents. 
Future alloy development will focus on the optimization of the microstructure 
in order to ensure a safe application. 
2. The corrosion rate of Zn-4Ag calculated from released Zn ions in DMEM 
extract was approximately (10.75 ± 0.16) μg cm-2 day-1, which is higher than 
the that of pure Zn. 
3. A cytotoxic effect decreasing viability and proliferation of L929 and Saos-2 
cells was observed, but only in the undiluted extracts of the Zn-4Ag alloy. 
However, this finding should not be overestimated, since the suitability of the 
used ISO 10993-5 standard method has to be discussed for degradable 
materials, according to each application. 
4. In vitro antibacterial evaluation showed the Zn-4Ag alloy has the potential to 
inhibit initial S. gordonii adhesion. 
Therefore, the biodegradable Zn-4Ag alloy exhibits excellent mechanical 
properties, predictable degradation behavior, acceptable cytotoxicity and 
effective antibacterial property in vitro, which make it a promising candidate for 
biodegradable implants. It should be investigated by further in vitro and in vivo 
studies.  
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3. Study II: Selection of extraction medium influences cytotoxicity of Zinc 
and its alloys 
The part is a reprint of the following publication: 
Ping Li, Christine Schille, Ernst Schweizer, Evi Kimmerle-Müller, Frank Rupp, 
Alexander Heiss, Claudia Legner, Ulrich E. Klotz, Jürgen Geis-Gerstorfer, Lutz 
Scheideler. Selection of extraction medium influences cytotoxicity of zinc and its 
alloys. Acta Biomaterialia (2019) DOI: 10.1016/j.actbio.2019.03.013 
Abstract: 
Zinc (Zn) alloys have been considered as promising absorbable metals, mainly 
due to their moderate degradation rates ranging between magnesium alloys and 
iron alloys. The degradation behavior depends on the specific physiological 
environment. Released metallic ions and corrosion products directly influence 
biocompatibility. The initial contact of orthopedic implants or vascular stents after 
implantation will be with blood. In this study, fetal bovine serum (FBS) was used 
as a model system of blood components. We investigated the influence of FBS 
on in vitro degradation behavior and cytotoxicity of pure Zn, and Zn-4Ag and Zn-
2Ag-1.8Au-0.2 V (wt%) alloys. The initial degradation rates in FBS were assessed 
and compared with the degradation and toxicity in four other common 
physiological model systems: DMEM cell culture medium ± FBS and McCoy's 5A 
medium ± FBS. Test samples in pure FBS showed the highest initial degradation 
rates, and accordingly, FBS supplemented media accelerated the degradation 
process as well. Moreover, an extract test according to ISO 10993-5 and -12 with 
L929 and Saos-2 cells was performed to investigate the role of FBS in the 
extraction medium. The cytotoxic effects observed in the tests were correlated 
with FBS-mediated Zn2+ release. These findings have significant implications 
regarding the selection of appropriate media for in vitro degradation and 
cytotoxicity evaluation of Zn and its alloys. 
3.1. Introduction 
Absorbable metals (also named biodegradable metals) refer to metals or their 
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alloys that degrade safely within the body [19, 51, 77, 119]. Three major metals, 
such as magnesium (Mg), iron (Fe), zinc (Zn), have been considered for medical 
applications. To date, Zn and its alloys have been proposed as promising metallic 
biomaterials due to their degradation behavior. Compared with Mg and Fe, the 
intrinsic standard corrosion potential of Zn (−0.76 VSCE), which determines the 
corrosion rate, is between Mg (−2.37 VSCE) and Fe (−0.44 VSCE) [3]. Nevertheless, 
pure Zn possesses relatively poor mechanical properties, which are insufficient 
for the majority of clinical applications. Zn-based alloys with superior strength 
have been fabricated by adding alloying elements, further improvements have 
been achieved by thermomechanical treatment [1, 2]. The mechanical properties 
of both Zn alloys investigated in this study roughly meet the generally 
acknowledged minimal requirements for implant materials, i.e. UTS > 250 MPa 
and elongation > 15%. Most importantly, previous in vivo studies found that the 
degradation products of pure Zn can be tolerated and metabolized, indicating that 
pure Zn can exhibit excellent biocompatibility [52, 57]. From the perspective of 
metallic biomaterials, the degradation behavior of alloys in the body affects their 
mechanical integrity and even directly influences biocompatibility and bioactivity 
via degradation products [13, 23]. Thus, it is critical to investigate the degradation 
behavior of Zn and Zn alloys in the specific physiological environment or the 
desired implantation site. 
For absorbable Zn alloys, proposed clinical applications mainly include 
cardiovascular stents and osteosynthesis materials [43, 53, 73, 119]. The local 
degradation environment for cardiovascular stents will be the bloodstream, and 
they will be in contact with the human blood until a neointima, a hyperplastic 
region of the vascular wall having histological characteristics of both intima and 
normal artery cells, has formed on the surfaces [19]. In addition, the ambient 
conditions of osteosynthesis materials are physically and chemically much more 
complicated and hard to predict. Nevertheless, the initial local environment after 
implantation will be a blood-filled cavity, mainly comprising a mixture of blood and 
interstitial fluid [102]. Thus, the initial contact both of stents and orthopedic 
implants after implantation will be with blood. However, the composition of human 
blood is much more complex compared to the artificial standard salt solutions 
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used in corrosion tests. In our previous studies, the initial degradation behavior 
of absorbable Mg alloys in whole human blood has been investigated. It is self-
evident and has been confirmed in several studies that simulated body fluids, 
such as phosphate-buffered saline (PBS), are insufficient to mimic the in vivo 
degradation behavior of Mg alloys in in vitro test systems [80, 120]. Except for the 
ionic component, the significant difference is that the blood contains large 
amounts of serum proteins compared to the standard salt solutions. These 
proteins will come into direct contact with implants in the initial stage and influence 
the degradation behavior. Fetal bovine serum (FBS) representing the cell and 
coagulation factor depleted fraction of fetal blood, is readily available in controlled 
quality. Therefore, FBS was widely employed to investigate the degradation 
behavior and cytotoxicity of Mg alloys in previous studies [102, 121]. However, 
the effect of FBS on Zn degradation behavior is widely unexplored. 
It is noteworthy that obvious cytotoxic effects of absorbable Zn alloys have been 
observed in extract tests based on the current ISO standards for cytotoxicity 
testing (ISO 10993-5 and 10993-12) [73, 74, 93, 122-124]. However, the excellent 
biocompatibility of pure Zn and Zn alloys observed in in vivo studies is 
indisputable [52, 53, 57]. The general discrepancy between in vitro and in vivo 
biocompatibility tests might limit the relevance of in vitro tests. Routinely, an 
extract test with a cell medium is used to investigate the cytocompatibility related 
to degradation products released from test materials. One of the advantages is 
that the extraction vehicle can be chosen to mimic the specific human body fluids. 
It can be assumed that the degradation behavior of alloys in the different 
extraction vehicles directly influences the results of cytotoxicity [67]. Previously, 
we reported that a high concentration of serum used in the extraction vehicle for 
Mg alloys, as a roughly blood-like environment, significantly affects the results of 
cytotoxicity in the extract test. This might be explained by the “protective” 
phenomenon of serum components forming a protective layer on Mg alloys, 
increasing corrosion resistance, and thus reducing the cytotoxicity of Mg alloys 
[102]. However, the influence of FBS on cytotoxicity of Zn alloys is not yet well 
understood. 
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In this study, the first objective was to investigate the role of FBS in the initial 
degradation behavior of pure Zn and its alloys using an immersion test under cell 
culture conditions. The second objective was to compare the influence of different 
extraction media with and without FBS on the cytotoxicity of pure Zn and its alloys. 
3.2. Materials and methods 
3.2.1. Sample preparation 
Two zinc-based alloys, a Zn-4Ag and a Zn-2Ag-1.8Au-0.2V (wt%) (denoted as 
Zn-Ag-Au-V) alloys were investigated. Details of the fabrication and 
characteristics of the alloys have been described in previous studies [69, 122]. 
The age hardened 0.5 mm thick sheets of Zn alloys were cut into the dimension 
of 30 mm × 10 mm. Likewise, pure Zn sheets were cut into 30 mm × 10 mm × 1 
mm in size. The entire surface of the samples was mechanically ground with 
silicon carbide abrasive papers up to grit 600 (CarbiMet P1200, Buehler, 
Düsseldorf, Germany) using a manual polisher (Metaserv, Buehler, Düsseldorf, 
Germany), immediately followed by ultrasonic cleaning in absolute ethanol in an 
ultrasonic water bath (Sonorex K102H, Bandelin, Berlin, Germany) for 10 min. 
Prior to tests, all specimens were further disinfected with ultraviolet (UV) radiation 
for 1 h in a workbench (Lamin Air HB2472, Heraeus Instruments Co., Hanau, 
Germany). To avoid interference of the native oxidation layer of pure Zn and Zn 
alloys, the procedure of polishing, cleaning and disinfection was performed within 
6 hours prior to all tests. 
3.2.2. Immersion test 
To correlate between initial degradation behavior and cytotoxicity, we used an 
extraction method adapted from previously established procedures [74, 93, 122]. 
The immersion tests were performed with a ratio of surface area to extraction 
medium volume of 3.0 cm2/mL, according to ISO 10993-12: 2012 [91]. All 
samples in the media were processed in parallel using standard 6-well culture 
plates (Cellstar; Cat# 657160; Greiner Bio-One, Frickenhausen, Germany) under 
standard cell culture conditions (95% relative humidity, 37 °C and 5% CO2) for 24 
± 1 h. 
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To further investigate the effect of FBS on degradation of Zn and Zn alloys, five 
different extraction media were prepared as follows: heat-inactivated fetal bovine 
serum (FBS; Cat# 10500-064; South American origin; Life Technologies Co., 
Grand Island, USA), Dulbecco's modified Eagle medium (DMEM; Cat# 21063-
029; Life Technologies Co. Paisley, UK), DMEM supplemented with 10% FBS, 
McCoy's 5A (Cat# M8403; Sigma-Aldrich Chemie GmbH, Steinheim, Germany) 
and McCoy's 5A supplemented with 15% FBS, respectively. For comparison with 
human extracellular fluid, the compositions of DMEM, McCoy's 5A and FBS are 
presented in Table 3.1 [101, 104, 125, 126]. Additionally, the composition of fetal 
bovine serum, as provided by Life Technologies Co., is listed in Table 3.2. 
Table 3.1. Main composition of DMEM, McCoy's 5A and FBS, compared to the human 
extracellular fluid 
* Data are given from the Ref in [101]; n.m., not mentioned in the reference literature. 
Composition 
Human extracellular fluid 
DMEM McCoy’s 5A FBS Blood 
plasma Interstitial fluid 
Inorganic ions (mM)  
Na+ 142.0 139.0 127.3 141.0 137.0 
K+ 4.2 4.0 5.3 5.4 11.2 
Mg2+ 0.8 0.7 0.8 0.8 n.m. 
Ca2+ 1.3 1.2 1.8 1.2 3.4 
Cl- 106.0 108.0 90.8 117.2 103.0 
SO42- 0.5 0.5 0.8 0.8 n.m. 
HPO42- 2.0 2.0 0.9 4.2 n.m. 
HCO3- 24.0 28.3 44.1 26.2 n.m. 
Organic components  
Protein 1.2 (mM) 0.2 (mM) - - 38.0 (g/L) 
Glucose (mM) 5.6 5.6 4.5 16.6 6.9 
Amino acids 2.0 (mM) 2.0 (mM) 1.6 (g/l) 0.4 (g/l) n.m. 
Concentrations of buffering agents (mM)  
HCO3- 24.0 28.3 44.1 26.2 n.m. 
HPO42- 2.0 2.0 0.9 4.2 n.m. 
HPr 16.0-18.0* - - - n.m. 
Tris-HCl - - 25.0 - n.m. 
Total 42.0-44.0 30.3 70.0 30.4 n.m. 
Reference [101, 125] [125] [101] [104] [126] 
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Table 3.2. The main composition of fetal bovine serum* 
Component Units Mean Range Component Units Mean Range 
Total Protein g/dL 4.2 4.0-4.3 Globulin (total) g/dL 1.3 1.1-1.5 
pH units 7.3 6.7-7.3 Alkaline Phosphatase U/L 262 2-319 
Osmolality mosm/kg 314 290-335 GG-Transpeptidase U/L 5.0 0-7.0 
Glucose mg/dL 130 107-144 SGOT U/L 60.4 28-161 
Hemoglobin mg/dL 14.2 5.8-23.0 Lactate Dehydrogenase U/L 559 
262-
1010 
Bilirubin mg/dL 0.2 0.1-0.4 Cholesterol mg/dL 34.2 19-54 
Uric Acid mg/dL 3.2 2.6-3.5 Low Density Lipoprotein mg/dL 2.8 0-7.0 
Urea Nitrogen mg/dL 14.4 15-18 High Density Lipoprotein mg/dL 6.5 5.0-9.0 
Creatinine mg/dL 3.1 2.8-3.3 Triglycerides mg/dL 219.5 73-1720 
Sodium meq/L 134 131-137 Growth Hormone ng/mL 131 126-138 
Potassium meq/L 15.1 12.9-14.2 Insulin uIU/mL 4.3 2.9-5.5 
Calcium  mg/dL 14.6 14.3-15.0 Estradiol pg/mL 13.8 
11.2-
17.5 
Chloride meq/L 104.9 102-108  Progesterone ng/mL 0.03 0.01-0.06 
Phosphorus 
(inorg.) mg/dL 11.2 
10.0-
14.0 Testosterone ng/mL 0.40 
0.38-
0.45 
Iron (total) ug/dL 195 189-204 T4 (Thyroxine) ug/dL 14.8 13.9-15.8 
Albumin g/dL 2.6 1.3-2.9 T3 ng/mL 1.2 0.9-1.4 
* Data are provided from the Life Technologies Corporation. 
3.2.3. Determination of degradation behavior 
The initial degradation rate was calculated by the concentrations of released 
metallic ions in the different media. For each respective measurement, six 
specimens of each sample were immersed in the different media, respectively. 
After incubation for 24 h, the pH value of the extracts was measured at room 
temperature using a 766 Calimatic pH-meter (Knick, Berlin, Germany). After that, 
the extracts were diluted with deionized water to a final volume of 10 mL. 
Subsequently, released metallic ion concentrations (Zn2+, Ag2+, Au2+ and V2+) 
were determined by using an inductively coupled plasma optical emission 
spectrometer (ICP-OES, Perkin-Elmer Optima 4300 DV, Rodgau, Germany). 
Three-time repetitions for each element were performed at two different 
wavelengths. Based on released metallic ion concentrations, the degradation rate 
(DR) was expressed as μg cm-2 day-1 using the following Eq. (1): 
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Degradation rate = ((Ctest - Cblank) × V)/(S × T) (1) 
Here, Ctest (μg/mL) is the released metallic ion concentration in the extraction 
media, Cblank (μg/mL) is the mean metallic ion concentration in the original media, 
V (mL) is the measured solution volume, S (cm2) is the specimen surface area, 
and T (day) is the incubation time. Afterward, a LEO 1430 scanning electron 
microscope (SEM) equipped with an energy dispersive X-ray (EDX) spectrometer 
(Carl Zeiss GmbH, Oberkochen, Germany) was used to detect the surface 
morphology of the samples and to analyze the chemical composition of the 
corrosion products after extracts preparation. 
3.2.4. Cytotoxicity test 
According to ISO 10993-5: 2009, an extract test was performed for cytotoxicity 
evaluation. A mouse fibroblast cell line (L929) and a human osteosarcoma cell 
line (Saos-2) were used [97]. Cytotoxicity evaluation was performed via two 
assays: cell viability and morphology were qualitatively analyzed by live/dead 
fluorescence staining with fluorescein diacetate (FDA) and ethidium bromide (EB), 
and cell metabolic activity was quantitatively analyzed by Cell Counting Kit-8 
(CCK-8). Ti-6Al-4V disks were used as negative control, and pure Cu foils were 
used as positive control. 
3.2.4.1. Cell culture and extract preparation 
L929 fibroblasts (DSMZ GmbH, Braunschweig, Germany) were cultured in 24 mL 
DMEM containing 10% FBS, 1% GlutaMAX (Cat# 35050-038; Life Technologies 
Co. Paisley, UK) and 1% penicillin/streptomycin (Cat# 15140-122; Life 
Technologies Co., Grand Island, USA). Saos-2 osteoblasts (DSMZ GmbH, 
Braunschweig, Germany) were cultured in 10 mL McCoy's 5A supplemented with 
15% FBS, 1% GlutaMAX and 1% penicillin/streptomycin. Both cells were gown 
in 75 cm2 cell culture flasks (Cat# 430641U; Corning Co., Tewksbury, USA) under 
standard cell culture conditions, and cells were passaged after reaching 
approximately 80% confluency. 
To further investigate the role of FBS in extract tests of Zn and its alloys, four 
different extraction vehicles were respectively prepared: DMEM, DMEM + 10% 
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FBS, McCoy's 5A and McCoy's 5A + 15% FBS, as described in Section 3.2.2. 
Before transferring to cell cultures, all alloy extracts of unsupplemented DMEM 
and McCoy's 5A were supplemented with FBS to provide comparable culture 
conditions (FBS-supplemented media) in all groups. Figure 3.1 illustrates the 
procedure of DMEM extract preparation in a schematic diagram. 10% FBS was 
added to the DMEM extracts (without FBS) prior to incubation of the cells with the 
extracts for 24 h. To maintain the same dilution factor in the corresponding, FBS-
supplemented extraction medium (DMEM + 10% FBS), the same amount of liquid 
in form of DMEM + 10% FBS was added to these extracts. The extracts of 
McCoy´s 5A medium were prepared likewise, using the same procedure. The 
extracts of McCoy's 5A were supplemented with 15% FBS. Afterward, the metallic 
ion concentration detected by ICP-OES were further calculated. 
 
Figure 3.1. Schematic diagram showing the experimental set-up for the investigation of 
the effect of FBS on extract test results. On the onset of the test, the extraction vehicles 
were chosen: pure DMEM and DMEM medium containing 10% FBS. After incubation for 
24 h, the extracts of pure DMEM were supplemented 10% FBS. For maintaining the 
same dilution factor, the extracts of DMEM medium were diluted 0.9-fold with fresh 
DMEM medium. 
3.2.4.2. Live/dead fluorescence staining 
The cell morphology and viability of L929 and Saos-2 cultured in sample extracts 
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were qualitatively evaluated by live/dead fluorescence staining, using Hank's 
balanced salt solution (HBSS, Biochrom AG, Berlin, Germany) containing 25 
μg/mL FDA and 1.25 μg/mL EB (Sigma-Aldrich Chemie GmbH, Taufkirchen, 
Germany). L929 fibroblasts and Saos-2 osteoblasts were respectively inoculated 
in 12-well culture plates (Costar; Cat# 3512, Corning Costar Co., NY, USA). The 
cell seeding density was set to 3 × 104 cells/cm2. L929 suspension and Saos-2 
suspension were adjusted to a density of 5 × 104 cells/mL, and then 2.4 mL of 
the suspensions were respectively seeded to each well and pre-cultivated 
overnight. Cell media were then replaced with the respective sample extracts. 
After 24 h the L929 and Saos-2 morphologies cultured in the different extracts 
were observed and photographed using a CK2 inverted microscope (Olympus, 
Tokyo, Japan) equipped with a 550D DSLR camera (Canon, Tokyo, Japan). 
Subsequently, sample extracts were removed, and the cells were gently rinsed 
with HBSS. Afterward, 1.5 mL staining solution was added to each test well and 
samples were stained for 10 min in darkness. After rinsing with HBSS, the cells 
were observed with an Optiphot-2 fluorescence microscope (Nikon, Tokyo, Japan) 
equipped with a 550D DSLR camera. Representative areas of the cell layer were 
photographed to document the amount of living and dead cells, stained by FDA 
and EB into green and red, respectively. 
3.2.4.3. Cell counting kit-8 assay 
The inhibition of the metabolic activity of L929 and Saos-2 cells in different 
sample extracts was quantitatively analyzed using the CCK-8 assay (Dojindo 
Laboratories Co., Kumamoto, Japan). Corresponding to the experiments with 
live/dead fluorescence staining, the cell seeding density was also set to 3 × 104 
cells/cm2. For tests, 200 μL of L929 and Saos-2 suspensions (5 × 104 cells/mL) 
were respectively seeded in 96-well culture plates (Cellstar; Cat# 655180; 
Greiner Bio-One, Frichenhausen, Germany) and cultured overnight. 
Subsequently, the cell medium was replaced by 150 μL sample extracts. After 
incubation for 24 h, extracts were replaced by 100 μL fresh medium without FBS 
to avoid interference of Zn alloy degradation products and serum with the 
tetrazolium-based assay. Afterward, 10 μL of CCK-8 reagent was added to each 
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test well and the cultures were incubated for 2 h, following manufacturer's 
instructions. The optical density (OD) was measured at 450 nm in a Tecan F50 
microplate ELISA reader (Tecan Austria GmbH, Grödig, Austria). To calculate 
relative metabolic activity compared to the negative control, the following formula 
was used: 
Relative metabolic activity (%) = ((ODtest-ODblank)/(ODnegative-ODblank)) × 100% (2) 
Here, ODtest is the mean OD value of the test groups, and ODnegative is the mean 
OD value of the negative control, ODblank is the mean OD values of the cell culture 
media with the CCK-8 reagent. As described ISO 10993-5: 2009 [25], a cytotoxic 
effect was defined as a metabolic activity of cells subjected to extracts of test 
materials below 70% of the negative control. 
3.2.5. Statistical analysis 
All data were tested for normal distribution by Shapiro-Wilk normality test and 
homogeneous variance by Levene test. Data sets with abnormal distribution 
(non-parametric data sets) were analyzed using the Kruskal-Wallis test followed 
by the Nemenyi post hoc test. Parametric data sets were analyzed using one-
way analysis of variance (ANOVA) with extraction medium as an independent 
factor, followed by the Tukey highest significant difference post hoc test. 
Parametric data sets with heterogeneous variance were analyzed using one-way 
ANOVA (homogeneous variance not assumed) followed by the Games-Howell 
post hoc test. Statistical analyses were analyzed using SPSS version 22.0 
software (IBM, Armonk, USA) and statistical significance was considered at P-
value < 0.05. 
3.3. Results 
3.3.1. Degradation properties 
To determine the effect of FBS on the initial degradation rate, samples were 
immersed in different media under cell culture conditions for 24 h. The initial 
degradation rate was assessed by metallic ion release detected by ICP-OES, as 
shown in Figure 3.2. Due to other metallic ion concentrations (Ag2+, Au2+ and V2+) 
being below the detection limit (< 50 μg/L), only Zn ion concentration in the 
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different media was quantified. According to the measurement of Zn ion release, 
all samples immersed in FBS showed the highest degradation rates. A 
comparison of degradation rates in media with and without FBS supplement 
confirmed the corrosion-promoting effect of FBS: the degradation rates of all 
samples in DMEM + 10% FBS (or McCoy's 5A + 15% FBS) respectively were 
higher than their counterparts in unsupplemented DMEM (or McCoy's 5A). 
ANOVA (without homogeneous variance) confirmed the statistically significant 
difference in the degradation rate. Games-Howell post hoc pairwise comparisons 
confirmed a significantly higher degradation rate (p < 0.05) for Zn-4Ag (16.29 ± 
6.28 μg cm-2 day-1) and Zn-Ag-Au-V (16.10 ± 5.88 μg cm-2 day-1) in DMEM + 10% 
FBS in comparison to Zn-4Ag (2.99 ± 0.68 μg cm-2 day-1) and Zn-Ag-Au-V (3.70 
± 0.57 μg cm-2 day-1) in unsupplemented DMEM. Likewise, post hoc pairwise 
comparisons showed that the degradation rates were significantly increased (p < 
0.05) for Zn-4Ag (9.01 ± 5.21 μg cm-2 day-1) and Zn-Ag-Au-V (6.72 ± 3.05 μg cm-
2 day-1) in McCoy's 5A + 15% FBS, compared to their counterparts of Zn-4Ag 
(0.18 ± 0.07 μg cm-2 day-1) and Zn-Ag-Au-V (0.23 ± 0.14 μg cm-2 day-1) in 
unsupplemented McCoy's 5A, respectively. As predicted, the initial degradation 
rates of Zn alloys in DMEM and McCoy's 5A were increased by supplementation 
with FBS in this test setup. 
 
Figure 3.2. Initial degradation rates of pure Zn, Zn-4Ag and Zn-Ag-Au-V alloys calculated 
from released Zn ion concentration in different media under cell culture conditions for 24 
h. Values are mean ± SD, n = 6; Significant differences are marked by asterisks 
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(significance level *p < 0.05, ***p < 0.001). 
Figure 3.3 demonstrates the SEM-EDX analysis of the surface morphology and 
elemental composition analysis of pure Zn and Zn alloys after immersion in 
different media. Visible to the naked eye, inhomogeneous thin degradation layers 
were formed on the surfaces of samples after immersion. SEM micrographs 
showed no obvious corrosion layers covering the whole surfaces, only a small 
amount of irregular tiny degradation particles distributed on the surfaces was 
detected. EDX analysis revealed the presence of the elements Zn, O, C, Cl, Ca, 
P and S in these degradation particles. 
 
Figure 3.3. The SEM-EDX analysis of pure Zn and Zn alloys after immersion in different 
media under cell culture conditions for 24 h. Representative SEM images of degradation 
products on the surfaces (scale bar = 50 μm). The EDX spectrum (inset red line) 
indicates the elemental composition of degradation products, corresponding to points 
marked with a yellow arrow (energy range between 0.0 keV and 5.0 keV). 
3.3.2. Analysis of alloy extracts 
Table 3.3 illustrates the pH values of sample extracts after 24 h. The pH value of 
all extracts stayed in the range of 8.0-8.5, no dramatic changes were observed. 
Although pH values of McCoy's 5A media were higher than of DMEM media, the 
pH tended in the opposite direction, indicating more hydroxide ion release in the 
DMEM-based media. Prior to the cytotoxicity test, sample extracts were further 
prepared as described in Section 3.2.4.1. The mean Zn ion concentration of 
sample extracts is summarized in Table 3.3. ANOVA (without homogeneous 
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variance) was employed to confirm statistically significant differences. 
Specifically, post hoc pairwise comparisons indicated statistically higher Zn ion 
concentrations in the extracts of DMEM + 10% FBS for Zn-4Ag (688.21 ± 264.87 
μM) and Zn-Ag-Au-V (679.89 ± 248.17 μM) when compared with the DMEM-
extracts of Zn-4Ag (129.19 ± 28.69 μM) and Zn-Ag-Au-V (159.11 ± 23.89 μM) (p 
< 0.05). In addition, ANOVA confirmed statistically significant differences of Zn 
alloys in the extracts of McCoy's 5A with or without FBS. Post hoc pairwise 
comparisons showed that the Zn ion concentrations in the extracts of McCoy's 
5A + 15% FBS for Zn-4Ag (365.03 ± 207.63 μM) and Zn-Ag-Au-V (273.96 ± 
121.37 μM) were significantly higher than their counterparts in the extracts of 
McCoy's 5A for Zn-4Ag (11.49 ± 2.87 μM) and Zn-Ag-Au-V (13.46 ± 5.63 μM) (p 
< 0.05). Nevertheless, the Kruskal-Wallis showed no statistically significant 
differences for the Zn ion release from pure Zn in media with or without FBS (p > 
0.05). Still, the overall tendency clearly indicated that the Zn ion concentration 
was increased by the presence of FBS in the extraction media. 
Table 3.3. The pH value and released Zn ion concentration of sample extracts. 
 DMEM DMEM + 10% FBS McCoy’s 5A 
McCoy’s 5A+ 
15% FBS 
pH value 
Initial 7.69 7.66 8.20 8.15 
Pure Zn 8.12 ± 0.09 8.08 ± 0.03 8.38 ± 0.02 8.23 ± 0.01 
Zn-4Ag 8.17 ± 0.03 8.13 ± 0.01 8.50 ± 0.05 8.33 ± 0.02 
Zn-Ag-Au-V 8.21 ± 0.03 8.16 ± 0.01 8.49 ± 0.01 8.38 ± 0.02 
Zn ion concentration (μM) 
Pure Zn 134.27 ± 14.30a 267.98 ± 153.04a 17.55 ± 7.19A 102.75 ± 16.21A 
Zn-4Ag 129.19 ± 28.69a 688.21 ± 264.87b 11.49 ± 2.87A 365.03 ± 207.63B 
Zn-Ag-Au-V 159.11 ± 23.89a 679.89 ± 248.17b 13.46 ± 5.63A 273.96 ± 121.37B 
Different superscript letters within a row indicate statistical significance of Zn ion concentration 
between media with and without FBS (p < 0.05) 
3.3.3. Cell morphology and viability 
To investigate the effect of FBS on cytotoxicity, cell morphologies of L929 and 
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Saos-2 cultured in the specified extracts for 24 h were documented by light 
microscope. Exemplary images of the respective cultures are shown in Figure 
3.4. The cell morphology of L929 cultured in DMEM extracts with FBS exhibited 
an irregular circular shape, and a fraction of the cells was floating in the extracts, 
which is consistent with the positive (toxic) control group. Although some L929 
cells were also suspended in the DMEM extracts without FBS, another part of the 
cells was adhering. These cells showed a spindle shape and clear cellular 
outlines, which was obviously different from the corresponding cultures in DMEM 
extracts with FBS. Furthermore, the optical images of Saos-2 osteoblasts 
incubated in McCoy's 5A extracts without FBS showed predominantly regular 
shaped morphologies with intact outlines, which is in agreement with the negative 
control group. In contrast, most Saos-2 osteoblasts in the McCoy's 5A extracts 
with FBS tended to lose their attachment resulting in a spherical shape, similar to 
the positive control group. 
 
Figure 3.4. Representative optical images of L929 fibroblasts incubated with sample 
extracts of DMEM and DMEM + 10% FBS, and Saos-2 osteoblasts incubated with 
sample extracts of McCoy's 5A and McCoy's 5A + 15% FBS for 24 h (magnification 160×; 
scale bar = 200 μm). Ti-6Al-4V alloy was used as negative control and pure Cu foil as 
positive control. 
Figure 3.5 shows live/dead fluorescence microscopy images of L929 fibroblasts 
and Saos-2 osteoblasts after incubation with the different extracts for 24 h. The 
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L929 fibroblasts were nonviable in the DMEM extracts with FBS, indicated by 
almost total red staining, comparable with the positive control. On the contrary, 
some green fluorescent L929 cells existed in the extracts without FBS, indicating 
that part of the cells survived. Thus, it can be inferred that cell viability inversely 
correlates with FBS supplementation. In addition, Saos-2 osteoblasts in the 
extracts of McCoy's 5A without FBS appeared more viable and spread. Although 
the density of living osteoblasts in these groups was slightly less than the density 
in the negative control group, dead cells were rarely observed. Regarding the 
extracts supplemented with FBS, the results of the Saos-2 cells corresponded to 
those observed with L929 cells, i.e. the cell viability was notably decreased. Again, 
according to the qualitative analysis based on fluorescence images, the presence 
of FBS in the extraction media inversely correlates with the viability of both cell 
lines used in this study. 
 
Figure 3.5. Representative fluorescence microscopy images of L929 fibroblasts 
incubated with sample extracts of DMEM and DMEM + 10% FBS, and Saos-2 
osteoblasts incubated with sample extracts of McCoy's 5A and McCoy's 5A + 15% FBS 
for 24 h. Ti-6Al-4V alloy was used as negative control and pure Cu as positive control. 
Cells were stained by live/dead fluorescence staining using FDA & EB, where the green 
fluorescence represents live cells stained by FDA and the red fluorescence represents 
dead cells stained by EB (magnification 100×; scale bar = 250 μm). 
3.3.4. Relative metabolic activity 
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To quantitatively determine the effect of FBS on cytotoxicity, an extract test was 
performed, measuring the relative metabolic activity of L929 and Saos-2 in 
different extracts for 24 h in comparison to the negative control, as shown in 
Figure 3.6. The results of the extract test showed that L929 fibroblasts exposed 
to the FBS-containing extracts from all samples displayed an extremely low 
relative metabolic activity (almost 0% of the negative control). The Kruskal-Wallis 
test confirmed statistically significant differences in the relative metabolic activity. 
Post hoc pairwise comparisons showed that L929 viability in all extracts without 
FBS was statistically increased compared to the respective counterparts with 
FBS (p < 0.001). Interestingly, L929 in the DMEM extracts without FBS of pure 
Zn had a relative mean metabolic activity above 70% of the control (less than 30% 
inhibition), which is considered as non-cytotoxic according to ISO 10993-5: 2009. 
Furthermore, Saos-2 osteoblasts cultured in the extraction media without FBS 
exhibited a relatively high metabolic activity of above 70% for all materials tested. 
In contrast, obvious reductions of those values (below 40% of the control) were 
observed for the extraction medium with FBS. The Kruskal-Wallis test followed 
by the Nemenyi post hoc test indicated generally significantly different relative 
metabolic activities for Saos-2 cells in extraction media with and without FBS (p 
< 0.001), respectively. Hence, the effect of FBS on cytotoxicity determined by 
relative metabolic activity is consistent with the results of the live/dead 
fluorescence staining. 
 
Figure 3.6. Box-and-whisker plot of relative metabolic activity of (a) L929 fibroblasts and 
(b) Saos-2 osteoblasts after 24 h incubation with extracts, determined by CCK-8 assay. 
Ti-6Al-4V alloy was used as negative control and set to 100%. Dashed lines represent 
70% of control, which is a cut-off line between toxic and nontoxic effects. The data of five 
independent experiments are shown as the box-and-whisker plot (maximum, 75th, 50th, 
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and 25th percentiles and minimum) and black dots for each measurement (n = 20); 
Significant differences are marked by asterisks (Significance level *** p < 0.001). 
3.4. Discussion 
3.4.1. Initial degradation behavior 
A standardized in vitro approach for biocorrosion studies for absorbable metallic 
implant materials like Zn alloys is still lacking. Standard corrosion experiments in 
buffered salt solutions like PBS or artificial saliva do not correspond to the clinical 
situation. Absorbable Mg- or Zn-based alloys are proposed as materials for 
orthopedic implants or stents. These implants are inserted either into a blood-
filled implant site or the blood system itself. The initial postoperative environment, 
affecting the corrosion behavior of these implants, therefore is blood. In the 
present study, to mimic the initial implantation environment, FBS has been 
chosen as an in vitro model of blood. In this model, the influence of FBS on the 
initial degradation behavior of pure zinc, Zn-4Ag and Zn-Ag-Au-V was 
investigated in an immersion test model performed under cell culture conditions, 
i. e. in cell culture media at 37 °C in an incubator. It has already been shown that 
the degradation behavior of Mg alloys under cell culture conditions is closer to 
the physiological environment [127, 128]. Based on the previous studies, the 
immersion test in this study was performed with cell culture medium as extraction 
vehicle, to enable the correlation between degradation behavior and cytotoxicity 
evaluation [93, 94, 122]. 
Considering the degradation mechanism, the degradation behavior of pure Zn in 
the body is intrinsically determined by a corrosion process that generally 
proceeds via an electrochemical reaction [23]. Generally, physiological body 
fluids exhibit a neutral to slightly alkaline pH (i.e., human interstitial fluid, or blood 
plasma, etc.), except for some partly acidic environments (i.e., gastric juice, or 
urine, etc.). Pure Zn has the tendency to be passivated in the nearly neutral 
physiological environment (pH value of human plasma: 7.35-7.45), according to 
the Pourbaix diagram. Thus, the initial degradation reactions were involved in the 
following anodic dissolution of the metal and the cathodic reduction of oxygen, as 
shown in from Eq. (3) to Eq. (5) [51, 77, 119]: 
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Anodic reaction: 2Zn → 2Zn2+ + 4e- (3) 
Cathodic reaction: 2H2O + O2 + 4e- → 4OH- (4) 
Zn(OH)2 formation reaction: 2Zn + 2H2O + O2→ 2Zn(OH)2 (5) 
In our experiments, pure Zn and Zn alloys are immersed in different extraction 
media. Initially, the interaction between the electrolyte-containing aqueous media 
and the Zn surfaces causes Zn2+ and OH- release based on the Eq. (3) and Eq. 
(4). Moreover, some corrosion particles on the Zn surface were formed, and EDX 
analysis revealed the presence of several elements such as Zn, C, O, Cl, Ca, P 
and S. It can be assumed that these elements found in the degradation particles 
derive mainly from chemical reactions with components of the different media, as 
listed in Table 3.1. Thus, these degradation particles might be mainly composed 
of zinc carbonates, zinc hydroxides and zinc phosphates, as reported in previous 
studies [89, 106, 129]. 
According to the determined degradation rates, it is obvious that FBS accelerates 
the initial degradation of pure Zn, Zn-4Ag and Zn-Ag-Au-V alloys. However, the 
underlying mechanisms of FBS mediated acceleration of Zn alloy degradation 
are unclear due to the complex nature of the interactions. Usually, apart from the 
corrosion properties of the alloy itself, the degradation rate mainly depends on 
the composition of the media used in the different in vitro tests [103, 127]. The 
factors influencing the degradation behavior are not only the inorganic ingredients 
but also the buffering system and organic components. As listed in Table 3.2, the 
composition of FBS is complex and variable, because serum is derived from 
individuals and differently processed. In fact, FBS is a mixture of various 
physiological components and contains serum proteins, polypeptides, fats, 
growth factors, hormones and required nutrients, etc. [130]. Serum proteins, as 
one of the main constituents, are in the range from 32 g/L to 70 g/L, with bovine 
serum albumin (BSA) being the major fraction and amounting from 20 g/L to 36 
g/L [126]. Törne et al. [131] demonstrated that rapid protein adsorption on Zn 
surfaces immersed in whole blood prevents the initial passivation of the surface 
by a protective zinc-phosphate layer, leading to an increased initial corrosion rate. 
Thus, one of the assumptions for this study was that the initial degradation rate 
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of the tested alloys might be influenced by serum protein. 
To our knowledge, only few studies have investigated the interaction between 
FBS and the corrosion behavior of Zn and its alloys. In most previous studies, 
FBS has been used to provide serum protein in simulated body fluids to 
investigate corrosion behavior of metals, such as Mg alloys [121, 132, 133]. 
Nonetheless, studies of the influence of the FBS on corrosion behavior of Mg 
alloys have also produced diverging results, and the corrosion mechanisms are 
not fully understood. For pure Mg, Yamamoto et al. [132] reported additional FBS 
might form a diffusion barrier on the surface of pure Mg, which decreases the 
degradation rate of pure Mg. Meanwhile, Liu et al. [133] also demonstrated that 
bovine serum albumin might elicit a 'protective effect' decreasing corrosion of the 
AZ91 magnesium alloy. Nevertheless, the effect of proteins on the corrosion of 
Mg alloys might depend on the surface characteristics of the samples or alloy 
composition. Gu et al. [134] found that the corrosion rate of a Mg-Ca alloy 
increased in DMEM with FBS whereas the AZ91 alloy showed the opposite 
tendency. Also, Johnson et al.[121] reported that the degradation rate of a Mg-Y 
alloy with an oxidized surface was reduced in the presence of FBS, but the 
degradation rate of the same alloy without an oxidized surface was increased by 
FBS. These varying trends imply that the influence of proteins on corrosion is 
more complicated than the simplistic adsorption hypothesis model. Importantly, 
for in vitro biodegradation tests of Zn alloys, the addition of FBS in the solution is 
essential to bridge the gap between simple ionic solutions and the more 
complicated physiological fluids in the body. However, the mechanisms of FBS 
on the degradation behavior of Zn alloys are still not fully understood and require 
further basic studies. 
3.4.2. Cytotoxicity evaluation 
As a potential candidate for biomaterials, biocompatibility and feasibility of 
different Zn alloys have been investigated by several previous studies [19, 51, 77, 
119]. However, the correlation between in vitro and in vivo biocompatibility results 
is poor. Specifically, the biocompatibility evaluation of Zn alloys in most previous 
studies exhibits an obvious toxic effect for the original undiluted extracts in 
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standardized cytotoxicity tests according to ISO standards 10993-5 and -12. The 
significant difference can be attributed to the fact that the current ISO standards 
were originally designed for screening the biocompatibility of non-absorbable 
materials. Due to the simplicity and feasibility of the experimental methodology, 
and to the worldwide acceptance of these harmonized standards by regulatory 
authorities, these standards were most commonly adopted for screening novel 
absorbable alloys [67, 135]. Considering the basic principles of the extract test, 
cytotoxicity was influenced by degradation products released from alloys via 
extraction with different extraction vehicles. Thus, the results were directly 
affected by three main factors: alloy properties, cell lines used and extraction 
conditions. 
In this study, one of the objectives was a comparison of the presence or absence 
of FBS in the extraction medium on the results of extract testing of Zn and Zn 
alloys. According to the analysis of alloy extracts (Table 3.3), the main 
degradation product released from the alloys was free Zn2+ ions in the mediaDue 
to buffering agents in the media, no dramatic changes of pH value were detected, 
and pH values stayed in the range of 8.0-8.5, implying that hydroxide ion release 
is limited. The previous study demonstrated no obvious decrease in cell viability 
of L929 cells when pH < 9 in the cell medium [136]. That means released Zn2+ 
ions in the extracts are mainly responsible for the observed toxic effect. In this 
study, cytotoxicity was assessed using different assays based on qualitative 
evaluation of cell viability and morphology, and quantitative measurement of cell 
metabolic activity. Qualitative and quantitative results proved to correlate very 
well. As shown in Figure 3.6, when media with FBS were used as extraction 
vehicle, mean relative metabolic activities below 70% were found for the Zn alloys, 
indicating more than 30% inhibition, which is the threshold for obvious cytotoxic 
effects in the abovementioned ISO standards. This indicates that the released 
Zn2+ concentration is beyond the cellular tolerance limit of L929 and Saos-2. For 
instance, in extracts of McCoy's 5A with FBS, the Zn ion concentration of Zn-4Ag 
and Zn-Ag-Au-V was 365.03 ± 207.63 μM and 273. 96 ± 121.37 μM, respectively. 
A comparison with the literature revealed that the range of Zn ion concentration 
in these extracts was far beyond most cellular tolerance limits, e.g., for L929 
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fibroblasts (< 80 μM) [93], human primary osteosarcoma cells U-2 OS (< 120 μM) 
[93], primary human coronary artery endothelial cells (< 100 μM) [137] and 
vascular smooth muscle cells (< 80 μM) [138]. The Ag concentration in the 
extracts was under the detection limit of OCP (approx. 0.5 µM). This is about 
factor 10 under the reported tolerance limit, indicating that Ag does not contribute 
to the toxic effects observed here [139]. 
The metabolic activity of both cell types tested was less decreased when media 
without FBS were used as extraction vehicle. For Saos-2 osteoblasts cultured in 
the extracts of McCoy's 5A without FBS, no obvious cytotoxic effects were 
observed for all test samples because all relative metabolic activities in the 
cultures were exceeding 70%. This finding corresponds also to the fact that the 
Zn2+ ion concentrations of Zn-4Ag (11.49 ± 2.87 μM) and Zn-Ag-Au-V (13.46 ± 
5.63 μM) in McCoy's 5A were lower than the maximum safe concentrations of 
Zn2+ for the Saos-2 osteoblasts. 
The results for the metabolic activity of L929 in the extracts of DMEM without FBS 
differed, especially for the Zn-4Ag and Zn-Ag-Au-V alloy, as shown in Figure 3.6a. 
One possible explanation can be that the Zn ion concentration in the extracts of 
DMEM with Zn-4Ag (129.19 ± 28.69 μM) and Zn-Ag-Au-V (159.11 ± 23.89 μM) is 
not much higher than the reported cellular tolerance of L929 for the Zn ion 
concentration (< 80 μM) [93]. 
Indeed, few studies have reported the absence of cytotoxic effects in original 
undiluted extracts of Zn-based alloys used in extract tests, as summarized in 
Table 3.4 [53, 87, 88, 113, 140-143]. Interestingly, the studies by Li et al. [53] 
have found no obvious cytotoxicity for ECV304 and MG63 cells in original extracts 
of Zn-1Mg, Zn-1Ca and Zn-1Sr alloys. Similarly, Xiao et al. [144] investigated the 
cytotoxicity of a Zn-0.05Mg alloy with an extract test and demonstrated 
cytotoxicity of Zn-0.05Mg extracts was in Grade 0 and Grade 1, indicating no or 
weak cytotoxic effects. It is worthwhile to note that the above studies used serum-
free cell culture media as an extraction medium, without explaining why an 
extraction medium without serum was chosen. In contrast, Kubásek et al. [93] 
investigated the cytotoxicity of a Zn-0.8Mg alloy and demonstrated an obvious 
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toxic effect for L929 fibroblasts and U-2 OS osteoblasts with the original extracts 
of the Zn-0.8Mg alloy, when cell media containing 5% FBS were used as an 
extraction medium. Likewise, previous work by Jablonská et al. [94] has 
demonstrated that the extracts prepared from untreated Zn-1.5Mg caused 
obvious cytotoxicity in L929 cells. Apart from the different alloys and cell lines, 
these discrepancies are probably explained by the fact that the cytotoxicity of Zn-
Mg alloys was increased by the presence of FBS in the extraction medium, which 
is principally in agreement with our results Another reason for the differing 
outcomes in several investigations are the different surface to volume ratios used 
in the extraction tests. In our study we used 3 cm2 / ml, which results in a more 
than twofold higher concentrated extract compared to 1.25 cm2 / ml as used in 
other studies. 
A critical issue regarding the extract test is the choice of an appropriate extraction 
vehicle. The current ISO standard for cytotoxicity testing (10993-5:2009) 
suggests three types of extraction vehicles, namely a) culture medium with serum, 
b) physiological salt solution or c) other suitable media. Culture medium with 
serum is explicitly recommended because it is able to extract polar and non-polar 
components as well and promotes cell culture viability. The standard also 
demands that the solvent selected as the extraction vehicle should simulate the 
conditions during clinical application as good as possible [97]. In general, the 
incubation of test surfaces with serum containing culture medium instantly leads 
to the formation of a layer consisting mainly of albumin and fibronectin. The layer 
acts as an diffusion barrier at the material interface, limiting the release of 
possible toxic components [135]. Likewise, as pointed out in our previous study 
concerning a biocompatibility screening of Mg alloys, this serum protein layer will 
also be formed after implantation and thus mimics the initial physiological 
situation in vivo to a certain extent [102]. Obviously, using an extraction medium 
with FBS can mimic the complex changes of the implant environment in the long-
term clinical situation only to a limited extent. For instance, osseous implants 
come into contact with serum due to the injury set by the implantation and 
subsequent blood coagulation, but serum is not the long-term physiological 
environment of these implants in vivo. For absorbable osseous implants 
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consisting of Zn alloys, therefore, developing a suitable extraction vehicle for a 
long-term extraction test simulating clinical conditions is still an issue which 
should be further investigated to better predict and evaluate biocompatibility. 
Table 3.4. Summary of the absence of cytotoxic effect in original undiluted extracts of 
absorbable Zn-based alloys used in extract test according to ISO 10993-5 and -12. 
*Rodent vascular smooth muscle cells (VSMC), human umbilical vein endothelial cells (ECV304), human 
osteosarcoma cells (MG63), murine fibroblast cells (L929), human osteosarcoma cells (Saos-2), human 
endothelium-derived cells (EA.hy926) and murine calvarial preosteoblasts (MC3T3-E1). 
**Relative cell viability (%) presents cell viability in original alloy extracts after incubation for 24 h, 
Alloys (wt%) Cell lines* 
Extract conditions 
Relative cell viability (%)** Ref. 
Medium SA:V (cm2/mL) 
Time 
(h) 
Zn-1Mg 
Zn-1Ca  
Zn-1Sr 
VSMC, 
ECV304, 
MG63 
Serum-free 
cell culture 
medium 
1.25 72 h 
ECV304 in all alloys 
extracts: > 80%a 
VSMC in all alloys extracts: 
60-80%a 
MG63 in all alloys extract: 
100-120% a 
[53] 
As-cast Zn–
1.2Mg MG63 
Cell 
medium 1.25 72 h 
MG63 in as-cast Zn–1.2Mg 
extracts: 80-90%b [88] 
Zn-0.05Mg L929 
Serum-free 
DMEM 
medium 
1.25 72 h L929 in the extracts: > 85% [140] 
Zn-1Mg 
Zn-1Mg-0.5Ca Saos-2 
DMEM with 
FBS 1.25 24 h 
Saos-2 in Zn-1Mg and Zn-
1Mg-0.5Ca extracts: > 
100% 
[141] 
Zn–1Mg–Ca 
Zn–1Mg–1Sr 
Zn–1Ca–1Sr 
MG63 n.m. n.m. n.m. MG63 in all alloys extracts: > 100% [87] 
Zn-3Cu-0.5Mg 
Zn-3Cu-1Mg 
EA.hy92
6 DMEM 1.25 72 h 
EA.hy926 in Zn-3Cu-0.5Mg 
and Zn-3Cu-1Mg extracts: 
80-100% 
[142] 
Zn-0.5Al 
Zn-0.5Al-0.1Mg 
Zn-0.5Al-0.3Mg 
Zn-0.5Al-0.5Mg 
MC3T3-
E1 n.m. n.m. n.m. 
MC3T3-E1 in all alloys 
extracts: 80-110%c [113] 
Zn-0.5Al-0.5Mg 
Zn-0.5Al-
0.5Mg-XBi 
where X = 0.1, 
0.3, 0.5 
MC3T3-
E1 n.m. 1.25 24 
MC3T3-E1 in all alloys 
extracts: 80-110%d [143] 
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compared to negative control. 
n.m., not mentioned in the reference literature. 
a Data gathered from the figure (Figure 5) in the literature [53]. 
b Data gathered from the figure (Figure 6a) in the literature [88]. 
c Data gathered from the figure (Figure 4e) after incubation for 2 days in the literature [113]. 
d Data gathered from the figure (Figure 10) after incubation for 2 days in the literature [143]. 
3.5. Conclusions 
In this study, the degradation rates of pure Zn, Zn-4Ag and Zn-Ag-Au-V alloys 
were evaluated in FBS, DMEM, McCoy's 5A, DMEM + 10% FBS, and in McCoy's 
5A + 15% FBS, respectively. The results demonstrate that the degradation rates 
of the test samples were affected by the composition of the media. Samples 
extracted in FBS showed the highest initial degradation rates, and 
supplementation of DMEM or McCoy's 5A with FBS notably accelerated the initial 
degradation process. Analysis of the released Zn ion concentration in the extracts 
showed that the decreased cytotoxicity observed in the extract media without 
FBS was obviously caused by the lower concentration of released Zn ions in 
these extracts. Therefore, besides tests with salt solutions, as used in standard 
corrosion tests, the influence of the serum components on the corrosion 
mechanism of Zn alloys should be further investigated. Likewise, selecting an 
appropriate extraction medium for cytotoxicity evaluation of Zn alloys should still 
be further studied based on the current standards. 
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4. Study III: Response of human periosteal cells to degradation products 
of zinc and its alloy 
The part is a reprint of the following manuscript: 
Ping Li, Jingtao Dai, Ernst Schweizer, Frank Rupp, Alexander Heiss, Ulrich E. 
Klotz, Jürgen Geis-Gerstorfer, Lutz Scheideler, Dorothea Alexander. Response 
of human periosteal cells to degradation products of zinc and its alloy. Materials 
Science and Engineering: C, manuscript under revision. 
Abstract: 
Zinc (Zn) and its alloys are proposed as promising resorbable materials for 
osteosynthesis implants. Detailed studies should be undertaken to clarify their 
properties in terms of degradability, biocompatibility and osteoinductivity. 
Degradation products of Zn alloys might affect directly adjacent cellular and tissue 
responses. Periosteal stem cells are responsible for participating in 
intramembranous ossification in fracture healing. The present study aims at 
examining possible effects emanating from Zn or Zn-4Ag (wt%) alloy degradation 
products on cell viability and osteogenic differentiation of a human immortalized 
cranial periosteal cell line (TAg cells). Therefore, a modified extraction method 
was used to investigate the degradation behavior of Zn and Zn-4Ag alloys under 
cell culture conditions. Compared with pure Zn, Zn-4Ag alloy showed almost 
fourfold higher degradation rates under cell culture conditions, while the 
associated degradation products had no adverse effects on cell viability. 
Osteogenic induction of TAg cells revealed that high concentration extracts 
significantly reduced calcium deposition of TAg cells, while low concentration 
extracts enhanced calcium deposition, indicating a dose-dependent effect of Zn 
ions. Our results indicate that the observed cytotoxicity effects were determined 
by the released degradation products of Zn and Zn-4Ag alloys, rather than by 
degradation rates calculated by weight loss. Extracellular Zn ion concentration 
determined the effect of osteogenic differentiation of TAg cells. These findings 
provide significant implications and guidance for the development of Zn-based 
alloys with an optimized degradation behavior for Zn-based osteosynthesis 
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implants. 
4.1. Introduction 
Absorbable zinc (Zn) and its alloys have been considered as potential materials 
for osteosynthesis implants [43-47]. Indeed, Zn-based alloys can address main 
drawbacks of current osteosynthesis materials, such as non-degradability issues 
caused by bioinert implants [13], low strength of polymeric implants [5], and 
unsuitable degradation behavior of magnesium-based or iron-based implants 
[145]. Most notable is the fact that Zn-based materials possess biocompatible, 
biodegradable, osteoinductive and antibacterial properties [48, 63]. The ionic zinc, 
as the main degradation product of Zn-containing chemical bonds or biomaterials, 
is one of the essential elements in the human body since it represents the metallic 
part of numerous proteins [48]. Moreover, the ionic zinc possesses superior 
osteoinduction and promotes new bone formation [49]. Nonetheless, pure Zn 
exhibits relatively low strength, insufficient for the most clinical requirements. By 
adding alloying elements, mainly including Mg, Cu, Ag, Ca, Sr, Al, Li and Mn, etc., 
to pure Zn mechanical strength can be enhanced substantially [145]. Previous 
studies reported that the Zn-Ag alloy exhibits superior mechanical properties 
compared with those of pure Zn [62, 89, 122]. Additionally, Zn-Ag based stents 
implanted into porcine iliofemoral arteries showed excellent biocompatibility and 
constant degradation behavior [62]. Meanwhile, incorporation of Ag ions into 
implants is beneficial for antibacterial properties and does not interfere or even 
disturb the process of bone regeneration [49]. However, it is not trivial to 
investigate the correlation between the degradation behavior within specific 
physiological environments and the impact of the resulting degradation products 
on biocompatibility. 
As potential osteosynthesis materials, the degradation products of Zn and its 
alloys not only directly participate in the adjacent cellular reaction but affect bone 
tissue regeneration as well. In general, bone fracture healing consists of a 
complex series of physiological responses, and the exact mechanism of the 
respective cells mediating bone healing is still unknown [146]. Admittedly, 
periosteal stem cells play an important role in callus formation and participate in 
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intramembranous bone formation in the bone healing process [147, 148]. 
Compared to other skeletal stem cells, periosteal stem cells can directly form 
bone tissue via the intramembranous pathway, and are also capable to induce 
endochondral ossification after trauma [148]. For bone regeneration therapies in 
the oral and maxillofacial surgery, jaw periosteal cells could represent the most 
suitable stem cell source. In previous and present works, we characterized this 
cell type in detail and optimized culturing conditions to advance step by step 
towards clinical use [149-152]. Zn-based alloys pins (Zn-1Mg, -1Ca, -1Sr) 
implanted into a non-fracture femora cavity induced new bone formation 
emanating from periosteum, indicating that zinc might induce periosteum-
mediated new bone formation [53]. Although the osteoinductive properties of Zn 
ions and Zn-containing biomaterials have been reported previously, the effect of 
degradation products of Zn and its alloys on cellular response of periosteal 
osteoprogenitor cells remains obscure. 
Biocompatibility of implant materials mainly depends on their degradation 
behavior in the body. Nevertheless, the suitability of current in vitro 
cytocompatibility tests for absorbable metallic materials has been controversially 
discussed [135, 153]. According to the ISO standards, a direct contact test is 
suggested to evaluate the cell response directly on the material interface. 
Obviously, for absorbable Mg and Zn alloys, various tested cells were not able to 
grow on the in vitro dynamic interface for long-term periods [154, 155]. In general, 
an extract test should investigate possible effects of degradation products of 
materials caused by the cell culture medium on cellular response [67, 156]. In 
most studies, performed tests cover only the initial degradation stage [67, 157, 
158]. Previously, we reported about a developed extraction method which 
correlates between initial degradation behavior and cytotoxicity of Zn and its 
alloys. The results indicated that cytotoxicity of Zn and its alloys is influenced by 
released Zn ion concentrations [122, 156]. In fact, during the degradation process 
of Zn and its alloys, various Zn degradation products, soluble (i.e., Zn2+ and OH-) 
or complex insoluble products (i.e., zinc phosphate) are produced, synergistically 
participating to the physiological response in vivo [44, 45, 52]. Herein, the 
influence of the long-term degradation products of Zn and its alloys on 
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cytocompatibility should be further investigated. 
In our study, a modified extraction method was used to investigate the 
degradation behavior of pure Zn and Zn-4.0 wt% Ag alloy (Zn-4Ag) under cell 
culture conditions. The paper also focuses on the effect of associated 
degradation products on cellular function of human immortalized cranial 
periosteal cells (TAg cells). The use of TAg cells was chosen due to their genetic 
and phenotypic similarity to the primary cells from which they derive. The 
immortalized cells seem to possess a higher osteogenic capacity compared to 
the parental cells, as reported previously [159]. Thus, our study is a 
comprehensive investigation of (i) the in vitro degradation behavior of Zn and Zn-
4Ag under cell culture conditions; (ii) the effects of associated degradation 
products on cell viability and osteogenic differentiation of TAg cells; (iii) the 
respective effects of pH and Zn ion concentrations on TAg cell response and (iv) 
the establishment of a modified extraction method to correlate in vitro long-term 
degradation behavior with the cellular response, offering a suitable screening 
method for the testing of absorbable Zn-based alloys. 
4.2. Materials and methods 
4.2.1. Materials preparation 
A Zn-4Ag (wt%) alloy was fabricated via conventional casting followed by a series 
of thermochemical treatments and pure Zn was prepared as a control, as 
described previously [122]. Subsequently, the ingots of Zn and Zn-4Ag were cut 
into 1.5 mm thick sheets. The as-produced pure Zn and Zn-4Ag sheets were cut 
into 23 mm × 8 mm × 1.5 mm in size. Prior to all tests, samples were ground with 
SiC abrasive paper up to grit 600 (CarbiMet P1200, Buehler, Germany), 
ultrasonically cleaned for 10 min in absolute ethanol, individually weighted with 
sensitivity of 0.1 mg, and immediately disinfected under ultraviolet radiation for 1 
h each side (Lamin Air HB2472, Heraeus, Germany). 
4.2.2. Experimental design 
To correlate between in vitro degradation behavior and cytocompatibility, we 
modified an extraction method (as illustrated in Figure 4.1) based on previously 
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established methods [93, 94, 122, 156]. In order to collect extract medium, Zn 
and Zn-4Ag sheets were incubated in DMEM/F-12 for 28 days under continuous 
medium change. Every other day, extract medium was collected and added to 
TAg cells in different concentrations (100%, 50%, 25%, 10%, 5% and 2% extracts, 
respectively). Cytocompatibility was evaluated at different time points: cell 
metabolic activity at day 2, 6 and 12, gene expression pattern at day 14 and 
osteogenic potential at day 21 and 28. Additionally, Zn extracts were analyzed in 
terms of metallic ion concentration, pH values and insoluble products. At the end 
of the experiment (day 28), surface characterization after immersion test was 
analyzed and degradation rates were calculated by weight loss. 
 
Figure 4.1. Draft of the experimental procedure with a time line (day) of performed 
experiments. Samples were incubated in DMEM/F-12 for 28 days. Sample media were 
exchanged every 48 h (plus signs) and the old ones were used for TAg cell cultivation at 
different concentrations. Extraction media were additionally used for the analysis of ion 
concentrations, pH values and the insoluble products. In order to visualize surface 
degradation of the samples, scanning electron microscopy (SEM) and element analysis 
(EDX) were performed at day 28. Cytocompatibility of Zn/Zn-4Ag alloys was assessed 
in terms of cell viability (cell counting kit-8 (CCK-8) at day 2, 6 and 12, orange arrows), 
gene expression (qPCR, at day 14, blue arrows) and osteogenic potential of TAg cells 
(Alizarin Red staining, ARS, at day 21 and 28, red arrows). 
4.2.3. In vitro degradation test 
All samples were immersed in pure Dulbecco's modified Eagle's medium/nutrient 
mixture F-12 (DMEM/F12; Life Technologies, Paisley, UK) and incubated under 
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standard cell culture conditions (37 °C, 95% rel. humidity, 5% CO2 and 20% O2) 
for 28 days. The surface area to medium volume ratio was set to 1.25 cm2/mL, 
according to ISO 10993-12: 2012 [91]. The media were refreshed every 48 h to 
simulate a semi-static immersion test. For analysis of sample extracts, pH values 
were recorded at each time point, and released metallic ion concentrations (Zn2+ 
and Ag2+) were detected by an inductively coupled plasma atomic emission 
spectroscopy (ICP-OES; Optima 4300DV, Germany). To determine the insoluble 
products, the extracts at 28 days immersion were collected and centrifuged at 
170 g for 5 min. The visible insoluble products were analyzed by using a scanning 
electron microscope (SEM) equipped with an energy dispersive X-ray (EDX) 
spectrometer at 10 kV (LEO 1430, Carl Zeiss GmbH, Germany). 
At the end of the immersion period, the degradation products on the sample 
surfaces were removed by incubation in 250 g/L glycine (NH2CH2COOH) for 10 
min, according to ISO 8407: 2009 [160]. Afterwards, the degradation rates were 
calculated by weight loss and expressed as μm/year, according to ASTM G31-
12a [161]. Degradation rate (DR) was calculated as DR = (8.76 × 107 × W) / (A × 
D × T), namely, W is the weight loss (g); A is the surface area (cm2); D is the 
density (g/cm3) and T is the immersion time (h). In addition, surface morphologies 
and chemical composition after immersion and removal of degradation products 
were analyzed by SEM-EDX. 
4.2.4. Cytocompatibility test 
4.2.4.1. Cell culture and extract preparation 
A human SV40 T-antigen immortalized cranial periosteal cell line (TAg cells) as 
described previously was used for cytocompatibility evaluation [159]. TAg cells 
were cultured in complete DMEM/F-12 supplemented with 10% fetal bovine 
serum (FBS, Sigma-Aldrich, Germany), 1% penicillin/streptomycin (P/S, Lonza, 
Switzerland), 1% amphotericin B (Biochrom, Germany), 0.25 mg/mL 
immortalization maintenance dose of G418 (Biochrom, Germany). TAg cells were 
cultured in either normal (Co) or osteogenically induced conditions (Ob) 
throughout the experiments. Osteogenic medium of TAg cells contained 
complete DMEM/F-12 medium supplemented with 100 μM L-ascorbic acid 2-
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phosphate, 4 μM dexamethasone and 10 mM β-glycerophosphate (Sigma-
Aldrich, Germany). 
To further correlate between degradation and cytocompatibility, the respective 48 
h extracts were used as cell culture media supplement, as described in Section 
4.2.3. Prior to transferring to cell culture, all extracts were further supplemented 
with 10% FBS, 1% P/S, 1% amphotericin B and 0.25 mg/mL G418-BC to adjust 
TAg cell culture conditions. For evaluation of the osteogenic potential, extracts 
were added to the normal and osteogenic medium, respectively. The original 
extracts under both conditions were diluted by the respective complete media to 
different concentrations (50%, 25%, 10%, 5% and 2% extracts, respectively). 
4.2.4.2. Cell counting kit-8 assay 
Cell counting kit-8 (CCK-8) assay was used to evaluate a potential inhibition of 
metabolic activities of TAg cells cultured under normal and osteogenic conditions 
containing sample extracts, according to ISO 10993-5: 2009 [97]. TAg cells were 
seeded in 96-well culture plates at a density of 3 × 103 cells cm-2. After 24 h, the 
medium was removed and replenished by gradient sample extracts containing 
normal and osteogenic medium, and respective normal and osteogenic media 
were used as the negative controls, respectively. After incubation for 2, 6, and 12 
days, sample extracts were replaced by 100 μL fresh DMEM/F-12 and 10 μL 
CCK-8 reagent (Dojindo Laboratories, Japan) was added to each well. After 
incubation for 2 h, optical density was measured by a microplate reader (Tecan, 
Austria) at a wavelength of 450 nm and relative metabolic activities were 
calculated, as described before [156]. 
4.2.4.3. Alizarin red staining 
TAg cells were seeded in 6-well culture plates at a density of 3 × 103 cells cm-2 
and pre-cultivated overnight. TAg cells were induced osteogenically for 28 days 
in the presence of 48 h sample extracts. After osteogenic induction for 21 and 28 
days, TAg cells were fixed with 4% formalin for 20 min. After washing with DPBS, 
cell monolayers were stained with alizarin dye solution (40 mM, Sigma-Aldrich, 
Germany) for 20 min and washed 4 times with deionized water. A colorimetric 
assay was carried out to quantitate the calcium phosphate precipitates according 
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to the instructions of the manufacturer (Osteogenesis Quantitation Kit, Merck 
Millipore, Germany). Briefly, Alizarin red dyes were dissolved from the 
monolayers over a period of 30 min by the addition of 10% acetic acid solution. 
The monolayers were detached from the well bottom by scraping. The samples 
were vortexed for 30 s and heated at 85 °C for 10 min, cooled on ice for 5 min, 
and then centrifuged at 20.000 g for 20 min. After neutralization of the 
supernatants by adding 10% ammonium hydroxide, quantification of calcium 
precipitates was performed using an ELx800 plate reader (BioTek Instruments 
GmbH, Germany) at a wavelength of 405 nm. 
4.2.4.4. Gene expression analysis 
RNA isolation from TAg cells was carried out at day 14 of osteogenic stimulation 
in the presence of Zn extracts, according to the manufacturer's instructions using 
the NucleoSpin RNA kit (Macherey-Nagel, Germany). The isolated RNA was 
photometrically measured and quantified (GE Healthcare, Germany). cDNA 
synthesis was performed using 200 ng of RNA and the SuperScript VILO kit 
(Invitrogen, USA), according to the manufacturer's instructions. The real-time 
LightCycler System (Roche Diagnostics, Germany) was used to quantify mRNA 
levels of Runt-related transcription factor-2 (RUNX2), alkaline phosphatase (ALP), 
osteocalcin (OCN) and the alpha-1 chain of type I collagen (COL1A1), 
respectively. The DNA Master Sybr Green 1 (Roche Diagnostics, Germany) and 
the commercial primer kits (Search LC, Germany) were used for 40 cycles of PCR 
amplification. Transcript levels of target genes were normalized to those of the 
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH, 
Serach LC, Germany). Calculated ratios in control groups were set as 1 (control) 
and induction indices in relation to this control were calculated. 
4.2.5. Effects of alkaline pH values and different Zn ion concentration on cell 
viability 
To evaluate the effect of alkaline media conditions induced by Zn degradation on 
cell viability, TAg cells were seeded in 96-well culture plates at a density of 3 × 
103 cells cm-2 and pre-cultivated overnight. Subsequently, the medium was 
replaced by normal complete DMEM/F-12 (Co) and osteogenic complete medium 
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DMEM/F-12 (Ob) of pH values intentionally adjusted to 8, 9, 10, 11 and 12, and 
the normal culture media as a negative control. After incubation for 24 h, the 
relative metabolic activities were determined by CCK-8 assay, as described 
above. 
To identify which Zn ion concentration modulated cell viability and osteogenic 
differentiation of TAg cells, separate experiments evaluating the effects of 
different concentrations of extracellular Zn ions were carried out. The normal 
complete DMEM/F-12 (Co) and osteogenic complete DMEM/F-12 (Ob) were 
adjusted to the respective Zn ion concentration gradient (2-100 μM) using a ZnCl2 
solution (Sigma-Aldrich, Germany). Cell culture media without supplemented Zn 
solution was used as a negative control. TAg cells were seeded in 96-well plates 
at a density of 3 × 103 cells cm-2 for 24 h. Subsequently, the medium was replaced 
by media containing various Zn ion concentrations and refreshed every other day. 
The relative cell metabolic activities were analyzed at day 2, 6, and 12, 
respectively, as described above. After initial testing of various Zn concentrations 
on cell vitalities, typical low (2 μM) and typical high (40 μM) Zn ion concentrations 
were further used to investigate a potential influence on the osteogenic 
differentiation of TAg cells. Mineral deposition and osteogenesis-related gene 
expression were analyzed using qPCR as described above. 
4.2.6. Statistical analysis 
All data were presented as mean and corresponding standard deviations. All 
assays were repeated at least three times to ensure reproducibility. Where 
applicable, all data sets were first analyzed concerning their normal distributions 
by the Shapiro-Wilk test. For comparisons between two groups, a Student's t-test 
was performed. Mann-Whitney U-tests were analyzed if normality tests failed. For 
comparisons of three or more groups, parametric data sets were analyzed by 
one-way analysis of variance (ANOVA), followed by Tukey's multiple 
comparisons test. Non-parametric data sets were analyzed by the Kruskal-Wallis 
test followed by Dunn's multiple comparisons test. Statistical analyses were 
analyzed using GraphPad PRISM (vision 6.01, GraphPad Software, Inc., San 
Diego, US). A P-value < 0.05 was considered as statistically significant. 
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4.3. Results 
4.3.1. In vitro degradation behavior of Zn and Zn-4Ag sheets 
In vitro degradation behavior was evaluated in DMEM/F-12 under cell culture 
conditions for 28 days. The degradation rates of Zn and Zn-4Ag alloy calculated 
by weight loss were 4.80 ± 0.82 μm/year and 17.38 ± 0.78 μm/year, respectively. 
A Student's t-test was used to confirm the statistically significant difference 
between both groups (p < 0.001). As already macroscopically visible, all samples 
showed after the respective immersion period a dark blackish surface without 
obvious bulk degradation products. Furthermore, the surface morphology and 
chemical composition of Zn and Zn-4Ag sheets after immersion for 28 days are 
shown in Figure 4.2. The degradation precipitations dispersed on sample 
surfaces are visible under two different magnifications. Compared with Zn-4Ag 
surfaces, less structures of white appearance were formed on Zn surfaces. SEM 
images at higher magnification showed that some tiny degradation particles were 
distributed on the surfaces but no obvious thick degradation layers covering the 
whole surfaces were visible. As shown in Figure 4.2e, EDX analysis indicated 
that Zn, C, O and P were identified as elemental composition of degradation 
products on the surfaces. Additionally, Figure 4.3 illustrates sample surfaces after 
removal of the degradation products. The surfaces of Zn and Zn-4Ag showed a 
relatively uniform degradation morphology, without extensive localized corrosion 
spots. 
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Figure 4.2. Representative SEM-EDX analysis of samples after immersion in DMEM/F-
12 for 28 days. SEM images showing (a,b) pure Zn and (c,d) Zn-4Ag alloy. The spots 
highlighted as red rectangles are shown in a higher magnification in b and d. (e) 
Representative EDX results from spots arrowed with yellow letters A/B and C/D in (b) 
and (d). 
 
Figure 4.3. Representative SEM images of pure Zn and Zn-4Ag alloy after removal of 
degradation products. SEM images showing (a,b) pure Zn and (c,d) Zn-4Ag alloy. The 
red rectangles correspond to the magnified degradation morphologies of (b) pure Zn and 
(d) Zn-4Ag alloy. 
4.3.2. Analysis of sample extracts during the 28-day period of immersion 
Figure 4.4 shows the metallic ion release of pure Zn and Zn-4Ag alloy in DMEM/F-
12 as well as the pH values of the respective extracts for the 28 day period of 
immersion. According to ICP-OES measurements, only Zn ions released from the 
Zn-4Ag sheets could be detected in DMEM/F-12. Released Ag ion concentrations 
were shown to be under the detection limit (< 50 μg/L). At all analyzed time points, 
the mean Zn ion release from samples was below 6.5 μg/mL (approximately 100 
μM). The tendency of Zn ion release was generally consistent between pure Zn 
and Zn-4Ag alloy (Figure 4.4a). As a simple calculation, the cumulative Zn ion 
release amount of pure Zn (81.7 ± 1.87 μg/mL) was slightly, but significantly 
higher than that of Zn-4Ag (79.1 ± 0.99 μg/mL) for the 28 day-period of immersion 
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(p = 0.015), independent of degradation rates calculated by weight loss. The 
evolution of pH values during immersion is illustrated in Figure 4.4b. Pure Zn and 
Zn-4Ag showed a similar trend of pH changes during immersion in DMEM/F-12. 
A rapid increase in pH values was detected at initial time points, thereafter 
constantly decreasing pH values were measured. All mean pH values measured 
were in the range from 8.4 to 8.9, so all pH changes were below 0.8 compared to 
the respective initial values. At the end of the 28-day period, mean pH values of 
8.42 and of 8.47 were measured for Zn-4Ag and Zn sheets respectively. 
 
Figure 4.4. Analysis of sample extracts during the 28 day-period of immersion. (a) Zn 
ion release (µg/mL and µM respectively) of pure Zn and Zn-4Ag in DMEM/F-12. (b) 
Evaluation of pH values. 
To further analyze the degradation products, the solid degradation particles in the 
extracts were analyzed by SEM-EDX. As shown in Figure 4.5a, a precipitation of 
insoluble degradation granules could be observed in Zn-4Ag extracts only after 
centrifugation. The SEM image shows that crystal-like degradation granules are 
visible (Figure 4.5b). The corresponding EDX spectrum revealed that the 
degradation granules of Zn-4Ag were mainly composed of Zn, O, C and Cl. 
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Figure 4.5. Analysis of degradation granules in Zn and Zn-4Ag alloys extracts after a 28 
day period of immersion. (a) Precipitates of degradation granules in Zn-4Ag extracts 
(indicated by the yellow circle) after centrifugation. (b) SEM images of the degradation 
granules marked with yellow letters. (c) The EDX spectrum indicates the elemental 
composition of spots marked with yellow letters in b. 
4.3.3. Examination of TAg cell functions after exposure to Zn and Zn-4Ag extracts 
Figure 4.6 shows the relative metabolic activity of TAg cells after exposure to 
various concentrations of Zn and Zn-4Ag extracts under normal and osteogenic 
conditions for 12 days. An inhibition of cell metabolic activity below 70%, 
compared to the negative control, was regarded as a cytotoxic effect, according 
to ISO 10993-5: 2009 [97]. Herein, TAg cells exposed to Zn or Zn-4Ag extracts 
exhibited relative metabolic activities above 70%, indicating that no cytotoxic 
effects are emanating from Zn extracts in all concentrations tested. In contrast, in 
the presence of low concentrated Zn-4Ag extracts (i.e., 25%, 10% and 5%), a 
significant increase in metabolic activities of TAg cells under normal and 
osteogenic conditions was observed at day 2 compared to the controls (p < 0.05). 
With increased culture time, there were no significant increases or decreases in 
metabolic activities of TAg cells, independent of various Zn extract concentrations 
at day 12 (p > 0.05). Notably, significant differences were detected only in TAg 
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cells cultured in the presence of Zn-4Ag extracts. 
 
Figure 4.6. Relative metabolic activities of TAg cells cultured in the presence of Zn and 
Zn-4Ag extracts for up to 12 days, determined by CCK-8 assay. (a, b) cell vitalities in the 
presence of pure Zn extracts of various concentration, (c,d) cell vitalities in the presence 
of Zn-4Ag extracts of various concentration under normal conditions (a, c) and under 
osteogenic conditions (b, d). The DMEM/F-12 complete media (normal and osteogenic) 
were considered as the negative controls and set to 100%. * represent p < 0.05 when 
compared to the negative control. 
For the analysis of a potential influence of Zn/Zn-4Ag extracts on osteogenic 
differentiation of TAg cells, one typical low (2%) and one typical high (50%) 
concentration of sample extracts was used. Figure 4.7a displays Alizarin red 
staining of TAg cells cultured in the presence of sample extracts in order to 
evaluate their osteogenic potential. Only weak Alizarin red staining was observed 
in TAg cell monolayers treated with 50% of sample extracts at day 21 and 28. In 
contrast, TAg cells cultivated in the presence of low concentrated (2%) sample 
extracts exhibited much stronger Alizarin red staining, indicating pronounced 
formation of calcium phosphate nodules (Figure 4.7b). For quantification of TAg 
cell mineralization, the ratio of Ca concentration in the extract-treated cultures 
was related to that determined in the control (TAg cells cultivated in the absence 
of Zn extracts) as illustrated in Figure 4.7 c and d. Significance tests were 
calculated by comparing Ca ratios of osteogenically induced TAg cells in the 
presence of extracts with those of cells in the absence of sample extracts. The 
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Kruskal-Wallis test showed significant differences at day 21. Dunn's multiple 
comparisons tests showed significantly higher Ca concentrations in the 
osteogenic control (ratio of 2.39 ± 0.44) compared with those cells cultivated in 
the presence of 50% Zn extracts (ratio of 1.13 ± 0.58; p < 0.001) and 50% Zn-
4Ag extracts (0.77 ± 0.27; p < 0.001). Nevertheless, no significant differences 
were detected when comparing the Ca ratio of osteogenic control (without Zn 
extracts) with those from cells cultivated in the presence of 2% Zn (ratio of 2.10 
± 0.29; p > 0.05) or 2% Zn-4Ag extracts (ratio of 1.96 ± 0.91; p > 0.05), 
respectively. By comparing Ca ratios in TAg cells cultivated under 2% and 50% 
of sample extracts, significant differences were obtained (p < 0.05). In addition, 
ANOVA was used to confirm statistically significant differences of Ca ratios at day 
28. Notably, post hoc pairwise comparisons showed significantly higher Ca 
concentrations in TAg cells cultivated in the presence of 2% Zn-4Ag (ratio of 3.23 
± 0.77) and 2% Zn (ratio of 2.63 ± 0.65) extracts compared with those of 
osteogenic control (ratio of 1.59 ± 0.23). Similarly, as already shown for Ca 
quantification after 21 days, significantly higher Ca ratios in TAg cells cultivated 
in the presence of 2% Zn extracts were detected compared to cells cultured in 
the presence of 50% Zn-4Ag extracts. 
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Figure 4.7. Detection of TAg cell mineralization exposed to Zn and Zn-4Ag extracts. (a) 
Alizarin red staining of TAg cells cultured in the presence of sample extracts under 
osteogenic conditions for 21 and 28 days. (b) Representative microscopic images of 
differentiated TAg cells cultured in the presence of sample extracts for 21 and 28 days 
(magnification 4×; scale bar = 500 μm). Quantification of calcium precipitates is shown 
at day 21 (c) and day 28 (d). The ratio of Ca concentration (osteogenic/normal culture 
condition) was quantitatively analyzed by dissolving the Alizarin dye from TAg cell 
monolayers. Statistical differences were calculated compared to the osteogenic control 
without extracts. * p < 0.05, *** p < 0.001. 
 
Figure 4.8. Quantitative gene expression of osteogenically induced TAg cells exposed 
to sample extracts for 14 days. Gene levels of osteogenically induced TAg cells in the 
absence of Zn extracts were set as 1 and induction indices in relation to this control were 
calculated. Relative expression of (a) Runt-related transcription factor-2 (RUNX2), (b) 
Alkaline phosphatase (ALP), (c) Osteocalcin (OCN) and (d) Alpha-1 chain of type I 
collagen (COL1A1) are illustrated. * p < 0.05, ** p < 0.01.and *** p < 0.001. 
Figure 4.8 shows gene expression levels of RUNX2, ALP, OCN and COL1A1 in 
osteogenically induced TAg cells at day 14 of immersion with or without Zn 
extracts. Statistically significant differences of COL1A1 expression were 
confirmed by ANOVA. Post hoc pairwise comparisons showed a significantly 
lower COL1A1 expression in osteogenically induced TAg cells in the presence of 
50% Zn-4Ag (p < 0.05) and 50% Zn (p < 0.05) extracts compared to the 
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osteogenic control (without extracts). By comparing COL1A1 expression in cells 
cultivated in the presence of 2% Zn (1.03 ± 0.14) and 2% Zn-4Ag (1.08 ± 0.15) 
extracts to that in cells cultured in the presence of 50% extracts of Zn (0.59 ± 
0.11, p < 0.05) and Zn-4Ag (0.52 ± 0.11, p = 0.014), significant differences were 
obtained. In addition, RUNX2, ALP and OCN expression was shown to be 
significantly decreased in TAg cells cultured in the presence of 50% Zn and for 
ALP also in the presence of 50% Zn-4Ag extracts (p < 0.05). Herein, the above 
results coincide with the result that high concentrations of Zn and Zn-4Ag extracts 
(50%) significantly reduced calcium deposition of TAg cells. 
4.3.4. Effects of different pH values and Zn ion concentrations on TAg cell viability 
Figure 4.9 shows the results of the relative metabolic activities of TAg cells after 
24 h incubation with the normal and osteogenic media adjusted to different pH 
values. For pH values below 9, no impact on TAg cell viabilities was detected (p > 
0.05). In contrast, when pH values reached 10, for both media conditions the 
relative metabolic cell activities were significantly decreased compared to the 
control (p < 0.05). 
 
Figure 4.9. Relative metabolic activities of TAg cells after a 24 h incubation period in 
normal and osteogenic media of various alkaline pH values. The original media were 
used as negative controls (N.C.). Undifferentiated TAg cells were denoted as Co, and 
osteogenically induced cells as Ob. * and # represent p < 0.05 when compared to the 
respective negative controls cultured under normal and osteogenic medium, respectively. 
In Figure 4.10, metabolic activities of TAg cells are plotted as a function of Zn ion 
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concentration (2-100 μM) under normal and osteogenic conditions. At day 2 of 
incubation (Figure 4.10a), low Zn ion concentrations (5-20 μM) significantly 
increased relative metabolic activities of TAg cells (p < 0.05) under both culture 
conditions. Zinc concentrations of 40-60 µM led to significantly higher cell 
activities only under normal conditions. If a Zn concentration of 100 μM was 
chosen, for both media conditions cell activities were significantly decreased 
compared to the control (p < 0.05). At day 6 of incubation, only Zn concentrations 
of 40 µM under normal conditions increased metabolic activity. At day 12 of 
incubation, TAg cell viabilities were almost comparable under normal and 
osteogenic conditions (p > 0.05). As already observed for day 2 and 6, Zn 
concentrations of 100 µM showed clearly cytotoxic effects. 
 
Figure 4.10. Relative metabolic activities of TAg cells treated with different Zn ion 
concentrations determined by CCK-8 assay. (a) 2 days of incubation, (b) 6 days of 
incubation and (c) 12 days of incubation. The original media served as negative controls 
(N.C.). * and # represent p < 0.05 when compared to the respective negative controls 
cultured under normal and osteogenic medium, respectively. Undifferentiated TAg cells 
were denoted as Co, and osteogenically induced cells as Ob. 
To identify whether Zn ions in the medium influence the osteogenic differentiation 
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of TAg cells, one typical low (2 μM) and one typical high (40 μM) Zn ion 
concentration were used. As shown in Figure 4.11a, the effect of Zn ion 
concentration on osteogenic differentiation was assessed by Alizarin red staining. 
A Zn concentration of 2 μM led to a clearly stronger Alizarin red staining 
compared to the staining of TAg monolayers which were incubated constantly 
with 40 µM Zn ions for 21 and 28 days. Almost no staining was observed at this 
Zn concentration. After 28 days, TAg cells cultured in 2 μM Zn ion media showed 
significantly higher Ca concentration than those in control and 40 μM Zn ion 
media (p < 0.001). In addition, TAg cells cultured in 2 μM Zn ion was statistically 
higher mineralization than that in control media at day 28 (p < 0.001). 
 
Figure 4.11. Mineralization of TAg cells treated with 2 μM and 40 μM Zn ion 
concentration. (a) Alizarin red staining of TAg cells under osteogenic conditions for 21 
and 28 days. (b) Quantification of calcium precipitates after osteogenic induction for 21 
and 28 days. The ratio of Ca concentration (osteogenically induced: untreated cells) was 
quantitatively analyzed by dissolving the Alizarin dye from cell monolayers, *** p < 0.001. 
4.4. Discussion 
4.4.1. In vitro assays for testing of absorbable metals for implants 
The ideal in vitro tests should simulate in vivo conditions to the utmost, in order 
to accurately predict the in vivo performance of implants. To date, in vitro assays 
for the evaluation of degradation behavior and cytocompatibility of absorbable 
metals have been controversially discussed, since both aspects were considered 
independently [128, 145, 162]. To overcome this shortcoming, the aim of our work 
was to develop a modified test design in order to be able to consider and analyze 
in vitro degradation behavior and cytocompatibility at the same time. 
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The aspect of the in vitro degradation behavior under cell culture conditions was 
performed based on previously published methods [163, 164]. It has been shown 
that the composition of cell culture medium is close to that of human extracellular 
fluids [101, 163, 164]. Additionally, DMEM was recommended as appropriate fluid 
to obtain a comparable in vivo degradation behavior of Zn [165]. Herein, 
DMEM/F-12 has been selected, whose main constituents were compared with 
human extracellular fluids (Table 4.1). Previous studies on the degradation 
behavior of Mg alloys under cell culture conditions (37 °C, 95% rel. humidity, 5% 
CO2 and 20% O2) reported on comparable conditions to physiological 
environments [127, 128] . The main reason was attributed to the fact that the 
bicarbonate buffer system in the medium requires triggering by active CO2, 
regulating pH values of the degradation medium, which is similar to the 
physiological conditions [166]. 
Table 4.1. Main composition of human extracellular fluids and the used medium. 
Composition 
Human extracellular fluid 
DMEM/F-12 [167] 
Blood plasma [101, 125] Interstitial fluid [125] 
Inorganic ions (mM) 
Na+ 142.0 139.0 150.6 
K+ 4.2 4.0 4.2 
Mg2+ 0.8 0.7 0.7 
Ca2+ 1.3 1.2 1.1 
Cl- 106.0 108.0 126.1 
SO42- 0.5 0.5 0.4 
HPO42- 2.0 2.0 0.5 
HCO3- 24.0 28.3 29.0 
Organic components 
Protein 1.2 (mM) 0.2 (mM) - 
Glucose (mM) 5.6 5.6 17.5 
Amino acids 2.0 (mM) 2.0 (mM) 1.3 (g/L) 
Concentrations of buffering agents (mM) 
HCO3- 24.0 28.3 29.0 
HPO42- 2.0 2.0 0.5 
Tris-HCl - - - 
Human protein 16.0-18.0 [101] - - 
Total 42.0-44.0 30.3 29.5 
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Standardized cytocompatibility evaluation tests for absorbable metals based on 
the ISO 10993-5 and -12 standards are not satisfactory based on the fact that 
they were developed for intentionally bioinert materials, neglecting the properties 
of absorbable materials [67, 145]. Attempts to improve the efficacy of in vitro 
evaluation methods for absorbable Mg-based and Zn-based metals, including the 
dilution of extracts [92, 168], the selection of extraction medium [102, 156], and 
the surface pretreatment [94, 169], have been reported. Considering the 
degradation properties of Zn and its alloys, various degradation products during 
long-term degradation process all participate in tissue healing in vivo [44, 45, 52]. 
Thus, in our test model, sample extracts were repeatedly collected during the 
degradation process and given to cultivated cells for cytocompatibility evaluation. 
4.4.2. Degradation behavior under cell culture conditions 
The in vitro degradation behavior of pure Zn and Zn-4Ag alloys in DMEM/F-12 
was analyzed under common cell culture conditions. According to our results, the 
following degradation mechanism in DMEM/F-12 can be proposed. Immersion in 
DMEM/F-12 (slightly alkaline solutions, pH value: 8.06) leads to anodic and 
cathodic reactions as described by Eq (1) and Eq (2), respectively [145]. With the 
dissolution of Zn, a rapid increase in Zn ion concentration and pH value can be 
detected in DMEM/F-12 (Figure 4.4). According to the Pourbaix diagram, Zn 
trends to be passivated in slightly alkaline solutions, while the chemical reactions 
as described in Eq (3) and Eq (4) take place. The accumulation of zincite (ZnO) 
and zinc hydroxide (Zn(OH)2) on the surfaces tends to form the passivation layers 
[156, 165]. On the other hand, the released Zn ions can spontaneously react with 
phosphate ions and carbonate ions contained in DMEM/F-12 to form Zn 
phosphate (Zn3(PO4)2·4H2O) and Zn carbonate (ZnCO3) [145, 165]. According to 
our EDX analysis, we detected the elements Zn, O, C and P on sample surfaces, 
as expected (Figure 4.2). 
Anodic reaction: Zn (s) → Zn2+ (aq) + 2e- (1) 
Cathodic reaction: 2H2O + O2 + 4e- → 4OH- (2) 
Zn(OH)2 formation reaction: Zn2++ 2OH- → Zn(OH)2 (3) 
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ZnO formation reaction: Zn2++ 2OH- → ZnO + H2O (4) 
Generally, the formation of Zn degradation layers can retard the degradation 
process [145, 170]. However, no obvious decrease in Zn ion release could be 
detected by ICP-OES measurements (Figure 4.4). It can be assumed that some 
organic components contained in DMEM/F-12 can interfere with the surface 
passivation, probably similar to the effect of protein adsorption on Zn surfaces 
[131]. Further on, more complex degradation products, such as hydrozincite 
(Zn5(CO3)2(OH)6) and simonkolleite (Zn5(OH)8Cl2·H2O) can be formed on the 
surfaces, as previously reported [145]. The formed degradation layers can be 
dissolved by chloride ion attack and transformed into zinc chloride salts, as 
confirmed by our EDX analysis from Zn-4Ag degradation granules, as illustrated 
in Figure 4.5. 
Our results revealed significantly higher degradation rates of Zn-4Ag alloys 
compared to those of pure Zn, probably due to the occurrence of a secondary 
phase (ε-AgZn3) within the microstructure [122]. A recent study reported on 
micro-galvanic effect between the Zn matrix and the secondary ε-AgZn3 phase , 
leading to high degradation rates [89]. Notably, the cumulative Zn ion release of 
pure Zn was significantly higher than that of Zn-4Ag alloy, which is inconsistent 
with our obtained degradation rates. We postulate that a fraction of free Zn ions 
released from Zn-4Ag surfaces rapidly binds to zinc degradation granules, which 
is not the case with those of pure Zn. As a consequence, a higher formation of 
degradation granules was observed in Zn-4Ag extracts (Figure 4.5). Thus, 
released Zn ion concentration in the sample extracts is not directly related to the 
degradation rates determined in our test. 
4.4.3. Assessment of cytocompatibility of Zn and Zn-4Ag alloys using 
immortalized periosteal cells 
Viabilities of TAg cells cultured in the presence of Zn and Zn-4Ag alloy extracts 
for up to 12 days were shown to be unaffected, indicating no obvious cell cytotoxic 
effects (Figure 4.6). Zn ion concentrations analyzed in all extracts were below 90 
μM after supplementation with 10% FBS (Figure 4.4a), indicating cell tolerance 
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for this concentration. This is in accordance with the tolerance level determined 
for TAg cells in this study by testing different extracellular Zn ion concentration 
between 2-100 μM, adjusted by the addition of a ZnCl2 solution (Figure 4.10). A 
significant improvement of TAg cell viabilities was achieved by low concentrations 
of either Zn-4Ag extracts or Zn ions at day 2 of examination (Figure 4.6 and Figure 
4.10). This result coincides with findings from previous studies describing the 
activation of vascular muscle or endothelial cell viabilities in the presence of low 
Zn ion concentrations [137, 138]. Ag ion concentration in the extracts from Zn-
4Ag alloys was under the detection limit of ICP-OES (< 0.5 μM). This Ag ion 
concentration remained under the previously reported cell tolerance limit (approx. 
4.25 μM), indicating that limited Ag ion release does not cause the toxic effects 
[139]. Due to the buffering effect of the DMEM/F-12 medium, pH values in all 
extracts were below 8.9 (Figure 4.4b). Under pH 9, we did not detect any 
significant decrease of metabolic activities of TAg cells (Figure 4.9). 
In our study, we detected fourfold higher degradation rates of Zn-4Ag alloys, but 
no higher cytotoxic effects emerged from them as compared to those of pure Zn. 
This finding contradicts the conclusion that cytotoxicity of Zn and its alloys is 
consistent with the variation of degradation rates [171, 172]. We postulate that 
during degradation of Zn-4Ag, free Zn ions were bound to degradation granules, 
leading to relatively low Zn ion concentrations in the analyzed extracts (Figure 
4.4). Therefore, we conclude that cytotoxicity of Zn and its alloys is mainly 
determined by available Zn ions. Previously, studies have reported on obvious 
cytotoxicity of undiluted extracts of Zn and its alloys towards bone-related cells 
[45, 122, 173]. DMEM/F-12 medium without FBS was chosen for the generation 
of Zn extracts. The presence of FBS in the extraction medium can increase Zn 
ion release, leading to additional cytotoxicity [156]. 
Periosteum derived mesenchymal stromal cells can differentiate into multiple cell 
lineages and play a critical role in bone regeneration [148, 149, 174]. We explored 
potential effects of long-term Zn degradation products on the mineralization 
potential of TAg cells considering the potential application of Zn-based alloys as 
suitable osteosynthesis materials. Our results showed that extracts of low 
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concentrations promote the osteogenic differentiation of TAg cells, in contrast to 
high concentrated extracts, indicating a dose-dependent effect (Figure 4.7). 
Similar effects on the mineralization potential of TAg cells were detected by using 
Zn ion concentrations of 2 μM and 40 μM in osteogenic media (Figure 4.11). In 
coincidence, other studies reported on osteogenic induction caused by Zn ion 
release from Zn-containing biomaterials [175, 176]. Zn-mediated cellular 
response seems to involve GPR39/ZnR and TRPM7 receptors for Zn-entry into 
MSCs, thus triggering the intracellular cAMP and PKA pathway, leading to the 
activation of MAPK [177]. Our qPCR data revealed no obvious increase in 
RUNX2, ALP and OCN gene expression at day 14, when TAg cells were cultured 
in the presence of low concentrated extracts (Figure 4.8) in comparison to TAg 
cells without extract supplementation. On the other hand, we observed a 
significant decrease in gene expression of the osteogenesis-relevant genes in 
the presence of high concentrated Zn extracts. A delayed osseointegration of 
pure Zn, characterized by less new bone formation directly on Zn surfaces, was 
observed in in vivo studies, which might be caused by the local accumulation of 
excessive Zn ion concentrations [45, 63]. Our data also verify the in vivo 
performances of Zn-based implants, indicating that the Zn ion concentration 
should be controlled in order to not disturb the bone tissue healing process. 
Nevertheless, the mechanisms of Zn modulated osteogenesis are still not fully 
understood and should be further investigated. 
4.5. Conclusions 
A modified extraction method was established for better correlation of Zn/Zn-4Ag 
alloy degradation behavior and cytocompatibility. Both Zn and Zn-4Ag exhibited 
predictable in vitro degradation behavior under cell culture conditions. Compared 
with pure Zn, a Zn-4Ag alloy with higher degradation rates seemed to exhibit no 
adverse cytotoxic effects on TAg cells. Concerning the degradation behavior, Zn 
ion concentrations in the extracts were not related to the calculated degradation 
rates of samples. This discrepancy is probably caused by formation of insoluble 
precipitates of degradation products, leading to a decreased concentration of free 
Zn ions in the extracts. This implies that cytotoxicity cannot be predicted by 
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calculated degradation rates, determined by e. g. sample weight loss, since it is 
correlated with released free ions rather than with degradation rates. In addition, 
osteogenic differentiation of TAg cells was significantly induced in the presence 
of low concentrated Zn extracts and significantly inhibited after supplementation 
of medium with high concentrated Zn extracts. Therefore, optimized Zn-based 
implants should produce low Zn ion concentrations in the local tissue to avoid 
interference with new bone formation. 
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5. Discussion 
The development of absorbable Zn-based CMF osteosynthesis implants requires 
a multidisciplinary approach to evaluate material properties and biological 
response. In our previous study, a novel Zn-4Ag alloy with improved mechanical 
properties was fabricated and developed [69]. Herein, this thesis highlighted the 
major material properties related to cytotoxicity, degradation behavior, 
antibacterial properties and osteoinductivity of Zn-based alloys as CMF 
osteosynthesis implants. 
5.1. Evaluation of cytotoxicity 
Predicting biocompatibility is of primary significance when assessing and 
screening the candidate implant materials. The in vitro standardized cytotoxicity 
test is a rapid, simple, sensitive method to determine whether a novel biomaterial 
does perform physiologically at a cellular level, without the release of any toxic 
substances [67, 135]. The cytotoxicity evaluation of Zn and its alloys is mainly 
performed by two methods, namely a direct contact test and an extract test, based 
on the current ISO standards. 
The in vitro direct contact test might be limited for Zn-based alloys due to the 
rapid surface change during the degradation process of Zn-based alloys. 
Considering most physiological conditions, cells have no chance to directly grow 
on the original surface of implants (without any protein adsorption and initial 
degradation layer formation) [68]. Previous studies have demonstrated that 
osteoblasts can grow directly on the degraded interface of Zn alloy [94] and on a 
gelatin modified Zn surface [178]. Notably, the comparison of results between in 
vivo and in vitro results have shown that the initial degradation layers formed on 
pure Zn in vivo, especially the zinc phosphate layer, can significantly enhance its 
biocompatibility [68]. Herein, we focused on extract tests to evaluate the 
cytotoxicity of Zn and its alloys in the thesis. 
In study I, the cytotoxicity of a novel Zn-4Ag alloy was evaluated with L929 and 
Saos-2 cells. The results indicated obvious toxic effects in the original extracts 
while the toxic effect was decreased in the diluted extracts (10% and 16.7%), as 
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shown in Figure 2.7 and Figure 2.8. The possible reason is the fact that the 
released Zn ion concentration in the original extracts is far beyond the cellular 
tolerance level for Zn ions, while L929 and Saos-2 cells can survive in the diluted 
extracts due to the decreased Zn ion concentration. Nevertheless, these 
cytotoxicity results should not be overestimated. The current ISO standard is 
derived from the evaluation of bioinert materials, such as titanium and ceramic, 
without consideration of the degradability of bioresorbable materials [67, 135]. 
Thereby, the use of the extract test for evaluating cytotoxicity of absorbable 
metals has been controversially discussed. 
In study II, we further explored the extraction conditions of an extract tests for Zn 
and its alloys. Different extraction media were compared. The outcomes revealed 
that relative metabolic activities of L929 cells and Saos-2 cells were significantly 
decreased in the extraction media containing fetal bovine serum (Figure 3.6), 
indicating an FBS-mediated cytotoxic effect. The probable explanation is that 
FBS significantly increases Zn ion release (Table 3.3), leading to Zn ion 
concentrations beyond cellular tolerance. Coincidentally, serum-free cell culture 
media were used as extraction vehicle in some previous studies, and no obvious 
cytotoxic effects in the original extracts of Zn alloys were observed as well [53, 
144] (Table 3.4). These results verify our finding of the FBS-mediated cytotoxic 
effect. Thus, our results can provide significant information for choosing an 
appropriate extraction medium to optimize the extract test. 
In study III, we modified an extraction method to correlate the degradation rate 
and related cytotoxicity. The results showed that the degradation rate of Zn-4Ag 
was almost four-fold higher than that of pure Zn under cell culture conditions. 
However, the relative cytotoxic effects were not significantly increased (Figure 
4.6). This can be explained by the finding that the released free Zn ion 
concentration in the extracts was not significantly different between pure Zn and 
the Zn-4Ag alloy (Figure 4.4). We assume that part of the free Zn ions was bound 
to degradation particles during the Zn-4Ag degradation process, leading to 
relatively low free Zn ion concentrations released from the Zn-4Ag alloy (Figure 
4.5). The result effectively denies the previous conclusion that cytotoxicity of Zn-
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based alloys is consistent with the variation of degradation rates [171, 172]. 
Therefore, we can conclude that cytotoxicity was determined by the released free 
Zn ions, not directly correlated with the degradation rate calculated by weight loss. 
Table 5.1. Summary of cytotoxicity evaluation of Zn-based alloys with bone-related cell 
lines. 
Samples 
Incubation 
time, d 
Key findings Ref. 
Murine osteoblast precursor cells (MC3T3-E1) 
Zn 
Zn-HA composite 
1, 2 and 4 
Zn-HA composite had better cell viability 
compare with the cytotoxic effect of pure Zn 
[44] 
Zn-0.5Al 
Zn-0.5Al-0.1Mg 
Zn-0.5Al-0.3Mg 
Zn-0.5Al-0.5Mg (C) 
2 and 7 
Zn-0.5Al-0.5Mg alloy exhibited higher cell 
viability compared with the Zn-0.5Al alloy. 
[113] 
Zn-0.5Al-0.5Mg 
Zn-0.5Al-0.5Mg-XBi 
where X = 0.1, 0.3, 0.5 
(C) 
2 and 7 
All alloys extracts showed no cytotoxicity while 
cell viability decreased with increasing Bi 
content 
[143] 
Pure Zn with ZnP, ZnO 
and Zn(OH)2 layers 
3 
ZnP had highly biocompatible, which might be 
the key controlling biocompatibility of Zn 
[68] 
Human osteosarcoma cells and osteoblasts (including MG63, U-2 OS, HOS, NHOst and Saos-2) 
Zn and Zn-4Ag 1 
Zn-4Ag had obvious toxicity effect in the original 
extracts while cytotoxicity decreased with 
diluted 
Study I 
Zn, Zn-4Ag 
and Zn-2Ag-1.8Au-0.2V 
1 FBS-mediated cytotoxic effect Study II 
Zn (SLM) and Zn-xMg 
(x=1,2,3,4) 
1, 3 and 5 
SLM Zn induced cytotoxicity for MG63 in 100% 
ectracts, but Zn-xMg had good cytocompatibility 
[172] 
Zn-0.8Mg (E) 1 
Alloy was cytotoxic effects to U-2 OS in 100% 
extracts but non-cytotoxic in 50% dilution. 
[93] 
Zn-1.2Mg (C,E) 3 As-cast Zn–1.2Mg had no toxicity to MG63 [88] 
Zn-1.5Mg (E) 1 Pretreatment improved cytocompatibility [94] 
Zn-1Mg, Zn-1Ca, Zn-1Sr 
(HR) 
1, 3 and 5 
Extracts had good viability using serum-free 
media 
[53] 
Zn–1Mg–Ca, Zn–1Mg–
1Sr 
Zn–1Ca–1Sr (C, HR) 
1, 3 and 5 
Cell viability and morphology of MG63 showed 
excellent cytocompatiblity 
[87] 
Zn-1Mg, Zn-1Mg-0.5Ca 
(C) 
1 and 2 Saos-2 cells tolerated 100% sample extracts [141] 
Zn-3Mg (C) 1, 3 and 7 
Sample extracts showed cytotoxicity after 1 day, 
while cell viability was improved at 3 day 
[111] 
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Human mesenchymal stem cells (including BMSCs and TAg cells) 
Zn and Zn-4Ag 2, 6 and 12 
Cytotoxicity of TAg cells mainly determined by 
degradation products  
Study III 
Pure Zn (W) 1, 3 and 5 
No cytotoxicity was detected in the 50% 
extracts, and confluent cell densities on Zn was 
observed 
[63] 
Pure Zn pretreated by 
serum (W) 
1, 7 and 14 
hMSC proliferation on Zn was increased after 1 
and 7 days while was decreased after 14 days 
compared with AZ31 
[177] 
The metallurgy techniques are indicated as follows: C: casting, E: hot extrusion, HR: hot rolling SLM, 
selective laser melting, W: commercial wrought product. 
For cytotoxicity evaluation, the proper choice of bone-related cell lines is deemed 
crucial to provide significant information on the applicability of the respective 
osteosynthesis implants. Table 5.1 lists the cytotoxicity results of Zn-based alloys 
using different bone-related cell lines, according to previous studies and our 
results. In study III, we first reported cytotoxicity results of Zn-4Ag alloys with 
human periosteal cells and found that no obvious toxicity effects. However, there 
are conflicting reports on the cytotoxicity of Zn and based alloys. These 
discrepancies can be explained by the different in vitro test methodologies, such 
as alloy systems, cell lines, exposure time, pretreatment, extract concentration, 
extraction medium etc. In summary, the current standardized cytotoxicity test 
should be further optimized to better evaluate and predict in vivo biocompatibility. 
5.2. Determination of degradation behavior 
Biodegradation behavior of absorbable Zn and its alloys not only influences the 
maintenance of mechanical strength but determines biocompatibility as well. 
Current standardized tests for evaluating in vitro degradation behavior are still 
lacking. In the thesis, the degradation behavior was investigated using an 
immersion test model (an extraction model with cell culture medium) under cell 
culture conditions, (37 °C, 5% CO2, 20% O2 and 95% rel. humidity). Numerous 
previous studies on Mg degradation have been demonstrated the in vitro 
degradation test under cell culture conditions is closer to the physiological 
environments [127, 128]. 
In study I, a novel Zn-4Ag alloy was performed to estimate the in vitro initial 
degradation rate through detecting the concentration of released metallic ions in 
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the cell culture medium. As shown in Figure 2.5, we observed higher degradation 
rates in DMEM medium than in McCoy’s medium, suggesting that the Zn 
degradation behavior is influenced by different components of the media. One 
main reason can be that the high concentration of HPO42- in McCoy’s medium 
formed a zinc-phosphate layer (passivation layer), inhibiting the initial 
degradation rates, as depicted in Figure 5.1. In addition, the initial degradation 
particles on the surfaces were detected by SEM (Figure 2.6). The EDX analysis 
indicates the products containing Zn, O, C, P and Cl derive mainly from chemical 
reactions with components of the cell culture media, probably composed of 
hydroxides, phosphate, carbonate compounds [43, 88, 106]. 
 
Figure 5.1. Schematic diagram of the degradation mechanism of Zn and its alloys under 
cell culture conditions (own image). 
In study II, we further investigate the effect of FBS on the initial degradation 
process under cell culture conditions. According to the results of ICP-OES, FBS 
can significantly increase the initial Zn ion released from pure Zn and its alloys 
(Figure 3.2). It can be hypothesized that serum protein interferes with the 
passivation layer formation (Zn-P layer), leading to increased Zn ion release, as 
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shown in Figure 5.1. Similarly, rapid protein adsorption on surfaces can prevent 
the initial passivation layer and increase the degradation rate when pure Zn is 
immersed in whole blood [131]. On the contrary, Liu et al. [179] reported that the 
Zn degradation process had three stages in artificial plasma. At the initial 24 h 
stage, Zn degradation can be retarded by the rapid albumin absorption on the 
surface. After 3 days, the degradation rate of Zn is increased mainly due to metal 
matrix dissolution. Whereas, the complex accumulation on the surface can 
decrease the degradation process again after 7 days. Additionally, a previous 
study also reported that the rapid protein adsorption on Zn surfaces can 
exacerbate the localized corrosion [165]. The conflicting results above can be 
found to reveal the complexity of the corrosion mechanisms. Hence, the effect of 
organic components on Zn degradation should be further explored. 
In study III, a Zn-4Ag alloy was immersed in the DMEM/F-12 under cell culture 
conditions for 28 days. A consensus is widely recognized that a long-term 
immersion test under cell culture conditions closely mimics the physiological 
environment [163-165]. Firstly, our results indicated an inconsistency between 
degradation rates calculated by weight loss and free metallic ion release detected 
by ICP-OES (Figure 4.4). This can be attributed to the formation of degradation 
particles in the extracts, leading to metallic ions bound to the particles (Figure 
4.5). In other words, the approach to estimate the degradation rates by detecting 
metallic ion release might be not suitable for a long-term degradation test. 
Moreover, the degradation rates of Zn-4Ag alloy (17.38 ± 0.78 μm/year) in the 
DMEM/F-12 is higher than that of pure Zn (4.80 ± 0.82 μm/year) caused by the 
micro-galvanic effect [89, 122]. Whereas, the degradation rates in DMEM/F-12 
are slightly lower than those in the standard salt solutions such as SBF and HBBS, 
as shown in the Figure 5.2 a. Additionally, Liu et al. [165] proposed that the Zn 
degradation process can be retarded in DMEM compared to that in SBF and 
HBBS, due to the synergy effect of both organic components and insoluble salt 
formation on the Zn surface. 
5. Discussion 
87 
 
 
Figure 5.2. Reported degradation rates of Zn and Zn alloys. (a) In vitro degradation rates 
calculated from immersion test with different solutions: cell culture medium (CCM), 
simulated body fluid (SBF) and Hank's Balanced Salt Solution (HBSS). (b) In degradation 
rates in the different implantation sites. The metallurgy techniques are indicated as 
follows: C: casting, E: hot extrusion, W: commercial wrought product and HR: hot rolling. 
Most data gathered from the literature [24]. 
Though the specific degradation rates of CMF implants should depend on the 
clinical application, mechanical integrity needs to be maintained for at least 3-6 
months. Also, the implants should be fully degraded within 2 years to avoid the 
interference of bone remodeling. Thereby, the suggested optimal degradation 
rate is 500 μm/year [24]. In the thesis, the in vitro degradation rate of the Zn-4Ag 
alloy was approximately 20 μm/year, which is probably insufficient for the 
requirements of CMF osteosynthesis implants. As shown in Figure 5.2 b, most 
previous in vivo studies reported that pure Zn and Zn-based alloys implanted in 
different sites showed relatively slow degradation rates, all below 500 μm/year. 
Consequently, it is required to adjust the degradation rates of Zn-based 
osteosynthesis implants in further studies. 
5.3. Investigation of biofunctionality features 
5.3.1. Antibacterial properties of a Zn-4Ag alloy 
Antibacterial properties of CMF osteosynthesis implants can prevent post-
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operative infections. An intraoral surgical approach is the main trend for 
management of maxillofacial trauma. For transoral maxillofacial surgery, the 
infection risk with oral bacteria is increased [76]. Admittedly, the antibacterial 
properties should be effective against the related microorganisms. A previous 
study reported that salivary microbial species mainly include Streptococcus, 
Rothia, Fusobacterium, Haemophilus, Prevotella, and Neisseria [180]. In that, S. 
gordonii plays a critical role in initial colonization through creating a biofilm for 
adhesion of other colonizers in the oral environment [181]. Therefore, we used S. 
gordonii to evaluate the antibacterial properties of a Zn-4Ag alloy potentially used 
for CMF osteosynthesis implants. 
In study I, the Zn-4Ag surface exhibited effective inhibition of initial S. gordonii 
adhesion and biofilm formation compared to the Ti-6Al-4V surface (Figure 2.9). 
Nonetheless, the potential antibacterial mechanism of Zn-4Ag is not completely 
understood and might be explained by several aspects as follows. Firstly, the 
released Zn ions from the Zn-4Ag alloy might potentially interact with S. gordonii 
on the surface. A previous study reported that Zn ions can alter charge balance, 
leading to cell deformation and bacteriolysis [182]. In principle, all zinc-based 
biodegradable materials possess potential antibacterial properties [48]. Secondly, 
the limited Ag ion release from a Zn-4Ag alloy might be useful for the inhibition of 
S. gordonii adhesion. Although Ag is considered as an effective antibacterial 
agent, the exact mechanism is still not completely understood. The effect is 
probably related to interaction with the cell membrane and interference with 
electron transport binding to DNA [183]. Additionally, released Ag ions can 
interact with DNA to promote pyrimidine dimerization via the photodynamic 
reaction, probably inhibiting DNA replication [184]. Finally, the antibacterial effect 
might be contributed by the cathodic reaction of Zn-4Ag in the medium, increasing 
hydroxide ion release on the surfaces (pH value increased). It has been reported 
that a magnesium alloy (AZ91) exhibited the in vitro antimicrobial properties 
mainly owing to the rapid degradation process, increasing in pH value in the 
culture medium. Nevertheless, the antibacterial effect is obviously diminished in 
vivo due to the buffering effect of body fluids [185]. Hence, the exact antibacterial 
mechanism of the Zn-4Ag alloy should be further investigated. 
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5.3.2. Osteoinductivity of Zn and Zn-4Ag alloy 
As an ideal osteosynthesis material, osteoinductivity can promote new bone 
formation, leading to shortening at the healing time. During the degradation 
process of Zn-based implants, the released Zn degradation products directly 
affect periosteal reaction and participate in tissue regeneration. Undoubtedly, 
periosteal stem cells not only can directly form bone tissue via the 
intramembranous pathway but induce endochondral ossification after trauma as 
well [147, 148]. Thus, we investigated the effect of degradation products of Zn 
and Zn-4Ag on the osteogenesis of a human immortalized cranial periosteal cell 
line (TAg cells). 
In study III, our key finding is that a high concentration of Zn degradation products 
can significantly inhibit the osteogenesis while a low concentration induces the 
osteogenic differentiation of TAg cells, indicating a dose-dependent effect (Figure 
4.7). Also, we used the related concentration of ZnCl2 to verify the dose-
dependent effect, suggesting that low Zn ion concentrations (2 μM) can induce 
osteogenesis but the osteogenesis inhibition by high Zn ion concentrations (40 
μM). Previously, Li et. al [53] reported that Zn-based pins (Zn-1Mg, -1Ca, -1Sr) 
implanted into a femur cavity can induce new bone formation under the 
periosteum, probably implying that zinc ions can promote periosteum-mediated 
bone formation. Similarly, an in vitro study demonstrated that the Zn-mediated 
cellular response seems to involve GPR39/ZnR and TRPM7 receptors for Zn-
entry into MSCs, thus triggering the intracellular cAMP and PKA pathway, leading 
to the activation of MAPK [177]. Admittedly, numerous studies substantiated that 
osteogenic induction can be caused by a low concentration of Zn ion release from 
Zn-containing biomaterials [175, 176]. Nevertheless, a phenomenon of delayed 
osseointegration around pure Zn implants was observed, probably caused by the 
local accumulation of excessive Zn ion concentrations [45, 63]. Thus, our results 
indicate that an appropriate Zn2+ release is essential for cellular reaction and 
function. Although the underlying in vivo mechanism remains unknown, 
controlling initial Zn2+ release should be of outstanding significance to improve 
biocompatibility, osteoinductivity and even osteointegration ability of Zn-based 
5. Discussion 
90 
 
alloys as osteosynthesis implants.
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6. Summary 
The thesis focuses on in vitro evaluation of a Zn-4Ag alloy as a potential 
biomaterial for CMF osteosynthesis implants, mainly including cytotoxicity, 
degradation behavior, antibacterial properties and osteoinductivity. 
Concerning the cytotoxicity test, obvious cytotoxic effects were observed in the 
original extracts. Nonetheless, we further demonstrated that the toxic effects were 
influenced by the presence of fetal bovine serum in the extraction medium mainly 
due to the FBS-mediated rapid Zn ion release. Moreover, the cytotoxicity is 
mainly determined by the degradation products released from Zn and a Zn-4Ag 
alloy rather than by their degradation rates. 
The degradation behavior of Zn and Zn-4Ag alloy was evaluated under cell 
culture conditions. According to the calculation of weight loss, the degradation 
rate of Zn-4Ag in the DMEM/F-12 was approximately 17.38 ± 0.78 μm/year, which 
is significantly higher than that of pure Zn (4.80 ± 0.82 μm/year). In addition, our 
results indicated that FBS can accelerate the initial degradation process of Zn 
and Zn alloys. 
The antibacterial evaluation showed that the Zn-4Ag alloy has the potential to 
inhibit biofilm formation of S. gordonii. Additionally, a modified extraction method 
revealed a dose-dependent effect on the osteogenic differentiation of human 
periosteal cells. Specifically, high concentration of sample extracts significantly 
reduced calcium deposition, while a low concentration can induce calcium 
deposition. 
In summary, the thesis indicates that Zn-4Ag possessed predictable cytotoxicity, 
relatively slow in vitro degradation behavior, effective antibacterial properties and 
potential osteoinduction capability, and thus could be a potential material for CMF 
osteosynthesis implants. However, further systematic studies are required. 
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7. German summary 
Die Arbeit konzentriert sich auf die In-vitro-Bewertung einer Zn-4Ag-Legierung 
als potentiellas Biomaterial für CMF-Osteosyntheseimplantate verwendet wird. 
Unters Dabei geht es hauptsächlich um Zytotoxizität, Abbauverhalten, 
antibakterielle Eigenschaften und Osteoinduktivität. 
Für den Zytotoxizitätstest wurden in den ursprünglichen Extrakten offensichtliche 
zytotoxische Wirkungen beobachtet. Wir konnten jedoch weiterhin nachweisen, 
dass die toxischen Effekte durch das Vorhandensein von fötalem Rinderserum 
im Extraktionsmedium beeinflusst wurden, was hauptsächlich auf die durch FBS 
vermittelte schnelle Freisetzung von Zn-Ionen zurückzuführen ist. Darüber 
hinaus wird die Zytotoxizität hauptsächlich durch die Abbauprodukte bestimmt, 
die aus Zn und der Zn-4Ag-Legierung freigesetzt werden, und nicht durch deren 
Abbauraten. 
Das Abbauverhalten von Zn und Zn-4Ag-Legierung wurde unter 
Zellkulturbedingungen evaluiert. Gemäß der Berechnung des Gewichtsverlusts 
betrug die Abbaurate von Zn-4Ag im DMEM / F-12 ungefähr 17,38 ± 0,78 μm/Jahr, 
was signifikant höher ist als die von reinem Zn (4,80 ± 0,82 μm/Jahr). Zusätzlich 
zeigten unsere Ergebnisse, dass FBS den anfänglichen Abbauprozess von Zn 
und Zn-Legierungen beschleunigen kann. 
Die antibakterielle Bewertung zeigte, dass die Zn-4Ag-Legierung das Potenzial 
besitzt, die Biofilmbildung von S. gordonii zu hemmen. Zusätzlich zeigte eine 
modifizierte Extraktionsmethode einen dosisabhängigen Effekt auf die osteogene 
Differenzierung menschlicher Periostzellen. Insbesondere die hohe 
Konzentration an Probenextrakten verringerte die Kalziumablagerung signifikant, 
während eine niedrige Konzentration eine Kalziumablagerung induzieren kann. 
Zusammenfassend lässt sich sagen, dass Zn-4Ag eine vorhersagbare 
Zytotoxizität, ein relativ langsames Abbauverhalten in vitro, wirksame 
antibakterielle Eigenschaften und eine potenzielle Osteoinduktionsfähigkeit 
aufweist, und somit ein potenzielles Material für CMF-Osteosyntheseimplantate 
sein könnte. Weitere systematische Studien sind jedoch erforderlich.
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